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ABSTRACT
MICRONUTRIENT STATUS AND TELOMERE LENGTH IN ADULT MEN
AND WOMEN
SEPTEMBER 2018
CHRISTY S. MAXWELL, B.S., UNIVERSITY OF MICHIGAN-FLINT
Ph.D. UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Elena T. Carbone

Background: Telomeres are the noncoding nucleotide sequences at the end of eukaryotic
chromosomes, serving to protect DNA during mitotic division. Given their guanine-rich
structure, telomeres are highly susceptible to oxidative damage often mediated by
inflammation. Recently, telomere attrition and dysfunction have been associated with
age-related diseases, including cardiovascular disease, type 2 diabetes, Alzheimer’s
disease, and certain cancers. Several modifiable risk factors have also been associated
with shortened telomere length, including physical inactivity, obesity, stress, smoking,
and poor diet.
Objective: We examined the relations between vitamin B12 status, folate status, and iron
status, relative to telomere length in eligible participants in the 1999-2002 US National
Health and Nutrition Examination Survey.
Design: Eligible participants had no evidence of kidney or liver disease, or pregnancy,
and had complete data on outcome, exposure and covariates (n = 5,941). Low B12 status
was defined as serum B12 ≤148 pmol/L or serum methylmalonic acid concentration ≥210
nmol/L. Folate status was defined as serum folate ≤13.4 nmol/L (suboptimal), and ≥45.3
nmol/L (elevated). Iron (Fe) status was defined as meeting ≥2 of the following criteria:
serum ferritin ≤15 µg/L, erythrocyte protoporphyrin >80 µg/dL, transferrin saturation
(TS)<20%, hemoglobin <12 (women) or <13 (men). Elevated Fe was defined as
TS>50%, serum Fe ≥155 µg/L (women) or ≥160 µg/L (men), or serum ferritin ≥150 µg/L
(women) or ≥200 µg/L (men) with no signs of inflammation.
Results: After controlling for covariates including, age, race/ethnicity, sex, BMI,
education level, smoking, alcohol intake, and blood glucose level, low B12 status in the
presence of elevated folate status was significantly associated with a shorter mean
telomere length in middle-aged adults. Elevated iron status was associated with a shorter
mean telomere length in adult men and women.
Conclusion: In middle-aged adults, low vitamin B12 in the presence of elevated folate
status was associated with significant telomeric attrition equivalent to 27 years of
additional biological aging. The shorter mean telomere length associated with an elevated
iron status was equivalent to 2.6 years of additional biological aging in adult men and
women. Thus, poor micronutrient status is associated with shorter mean telomere lengths
in adult men and women.
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CHAPTER 1
REVIEW OF TELOMERES
A. Background
Telomeres are repetitive, non-coding nucleotide sequences at the end of all
vertebrate chromosomes (TTAGGG in humans). They function as protective caps and
play an indispensable role in chromosome replication and stability (McClintock, 1941).
The guanine-rich 3’ projection is thought to be of particular importance; acting as a
buffer to protect gene coding sequences enabling gene continuity through DNA
replication. The theory of a “buffering” segment of DNA was first reported by Olovnikov
in 1973, where he properly ventured that with each round of cell division, a portion of
this segment (telomere) would be lost, without interruption to DNA function.
Furthermore, he stated that the length of each telomere would be important in
determining the cell’s ability to proliferate (Montpetit et al., 2014).
Telomeres have been accepted as essential components in cellular biology with
the 2009 Nobel Prize in Physiology or Medicine going to Elizabeth Blackburn, Carol
Greider, and Jack Szostak for their discovery of how chromosomes are protected by
telomeres and the enzyme telomerase. Due to its linear formation, eukaryotic
chromosomal DNA requires both the established DNA polymerase as well as the RNA
enzyme telomerase to complete the replication process (Blackburn, 1991).
Oxidative stress mediated by reactive oxygen species (ROS) is responsible for
single strand breaks in DNA where the telomeric GGG (guanine) end is highly
susceptible to damage (Matthews et al., 2006; Von Zglinicki, 2002). This susceptibility,
coupled with the knowledge that telomeric DNA has a reduced ability for repair, is
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suggestive of accelerated loss and cell death under such ROS stressors. With each round
of mitosis, telomeric DNA naturally shortens, resulting in cell senescence once a critical
degree of telomere attrition has been reached (Blackburn, 1991). In cell culture, acute
DNA damage induces premature “replicative senescence” mediated by accelerated
attrition of telomeres (Matthews et al., 2006; Von Zglinicki, 2002).
Telomere attrition is now a widely accepted cellular event associated with natural
aging. Moreover, telomere attrition and dysfunction have been shown to be causal factors
in many age-related diseases. Thus, telomere length assessment embraces potential as a
biomarker of risk assessment for numerous diverse health outcomes. There are many
methods used in determining telomere length, all with advantages and disadvantages
depending upon the specific study parameters.
1. Telomere Assessment
Several assessment methods may be utilized in determining telomere length. The
following briefly describes the primary methods, along with their strengths and
weaknesses.
a. Terminal Restriction Fragmentation
Southern Blot analysis of terminal restriction fragments (TRF) is the original
method developed for determining telomere length, and thus is often referred to as the
“gold standard” method. Here, genomic DNA is enzymatically digested in a manner that
preserves the telomeric DNA. Intact telomeres from all chromosomes are resolved using
gel electrophoresis, with fragments identified via Southern Blot analysis. Varying lengths
will present as a smear, with size being compared to a DNA standard (Montpetit et al.,
2014).
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Strengths of the TRF method include the ability to compare the results to other
investigator’s data, as well as, providing a kilobase size estimate for the telomere length.
Limitations include the possible overestimation in the true telomere length due to nonspecificity of the enzymatic process. The DNA must be of high-quality and not degraded,
thus collection and storage techniques must be carefully monitored. Results can vary
between labs depending upon the restriction enzymes used. In addition, TRF requires
large amounts of DNA (mg) per sample, which may prohibit its use in large-scaled
studies (Montpetit et al., 2014).
b. Polymerase Chain Reaction-Based Techniques
The initial qPCR technique was developed by Cawthon et al. in 2002 and is used
most frequently by researchers. Telomere length was quantified by comparing the amount
of telomere amplification product (T) to a single-copy gene (S), both performed in
separate tubes (Cawthon, 2002). The T/S ratio was calculated to yield a value that
correlates with the average telomere length. Favorably, this technique requires minimal
amounts of DNA (ng), is performed for a reasonable cost, and is amenable to high-output
testing, making it well suited for large epidemiological studies. A shortcoming however,
involves the possibility of intra-operator pipetting errors; thus, variations in the amount of
DNA present in the “T” and “S” tubes could compromise the precision of the assay. In
addition, the qPCR method results in variations, which limits the ability to allow for
comparisons between studies (Montpetit et al., 2014).
c. Single Telomere Length Analysis (STELA)
The STELA method is a qPCR-based method that was developed to detect the
length of specific, individual telomeres. While the first two methods discussed provide an
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average telomere length, this method provides the means for recognizing the presence of
short telomeres on a single chromosome. This method is useful in studies investigating
the presence of critically short telomeres of specific cells in low concentrations.
Limitations include the inability to identify long telomere lengths, as well as its laborintensive, technically challenging protocol (Montpetit et al., 2014).
d. Quantitative Fluorescence in situ Hybridization (Q-FISH) Methods
Q-FISH methods involves assessing metaphase chromosomes (or interphase
nuclei) following a fluorescence labeling. In contrast to the TRF and qPCR methods, QFISH utilizes cells as the substrate, rather than DNA. In general, Q-FISH assays have the
advantage of estimating sizes for each of the individual 92 telomeres in humans (and not
limited to an average or short lengths). These assays have been essential in providing
information about variation in length of telomeres between different chromosomes and is
particularly valuable in measuring telomere length in rare cells. However, the metaphase
Q-FISH approach is labor intensive, expensive, and difficult to perform, making it
impractical for large-scale epidemiology studies. An adapted version of this Q-FISH
method is called flow-FISH, which has the capability of sorting cells into subpopulations
based on size, granulation, and/or antibody labeling. Flow-FISH was the first assay to be
used clinically in diagnosing individuals with dyskeratosis congenital – a condition
associated with shortened telomere lengths (Montpetit et al., 2014).
Further Q-FISH approaches, as well as other methods including the hybridization
protection assay (HPA) and single-strand 3’ overhang measurement methods are also
available. As with the methods described above, each have strengths and weaknesses
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associated with measuring telomere length, but are utilized much less frequently in
epidemiological studies (Montpetit et al., 2014).
2. Non-Modifiable Determinants of Telomere Length
a. Sex and Telomere Length
Aging is a non-modifiable factor that inevitably results in telomeric attrition. Sex
and race are two other factors that are genetically predetermined and may influence
telomere length. Gardner et al. (2014) conducted a systematic review and meta-analysis
on sex and telomere length. Some studies have found longer leukocyte telomeres in
women than in men, while others have found no association, or even the reverse.
Theories as to why women may have longer telomeres include the role of estrogen.
Telomerase contains an estrogen-responsive element that is thought to stimulate
telomerase activity (Mayer et al., 2006). Additionally, telomeres are highly sensitive to
oxidative stress and women produce less reactive oxygen species (ROS) than men
(Nawrot, Staessen, Gardner, & Aviv, 2004). It has also thought that the antioxidant
properties of estrogen may allow women to metabolize ROS more efficiently, thus
protecting the susceptible telomeric strands.
From a potential 10,149 studies, Gardner et al. included 40 datasets in the metaanalysis. Telomere length was determined by Southern Blot (17 datasets), qPCR (19
datasets) or Flow-FISH (four datasets) in the eligible studies. There was little evidence
that the association between sex and telomere length varied by age group, but it did vary
by measurement method. The summary estimates of effect showed longer telomeres in
females than in males only in the Southern Blot method. The investigators concluded that
the failure of the qPCR and Flow-FISH methods in finding longer telomere lengths in
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females compared to males was due to higher experimental variability in the techniques
(Gardner et al., 2014).
b. Race/Ethnicity and Telomere Length
Racial disparities have been associated with lower life expectancy, higher rate of
disability, and earlier onset of chronic disease (Murray et al., 2006; Rewak et al., 2014).
One theory as to these disparities is the “weathering” hypothesis that Geronimus et al.
(1992) first suggested. This theory explaining such disparities, suggests that differences
found in populations in the early stages of chronic disease, result from different life
experiences, stress exposures, and access to coping resources associated with social
identities or “assignments” such as race/ethnicity, from conception through adulthood.
Nonetheless, data on race/ethnicity and telomere length have differed. Several studies
have found longer telomere lengths in black compared to white participants (Adler et al.,
2013; Aviv et al., 2008; Hunt et al., 2008; Needham et al., 2013). In contrast, Geronimus
argued these findings were the result of highly selected samples that included few to no
social covariates (Geronimus et al., 2015). In this study, Geronimus et al. investigated the
relationship between race-ethnicity, poverty, and urban stressors and telomere length in a
community-based study in Detroit, Michigan. In a sample of 202 black, white, and
Mexican adults taken from three Detroit neighborhoods, the investigators measured
telomere length and self-reported survey data including information on SES,
psychosocial, neighborhood, and behavioral stressors. The investigators found that after
stratifying each racial/ethnic group on a poverty-to-income ratio (PIR), black participants
had shorter mean telomere length compared to nonpoor white participants. However, this
finding was not significant. The authors found that all racial/ethnic groups were sensitive
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to the addition of socioeconomic, psychosocial, coping, and biobehavioral variables when
added to the model.
Interestingly, the authors also found that poorer whites had significantly shorter
telomere lengths than non-poor whites (p<0.01); whereas this relationship with poverty
was not observed among the black or Mexican participants. The authors cite that whites
may be more sensitive to their perceived socioeconomic failures when the expectations of
white privilege and the current circumstances are not congruent (Geronimus et al., 2015).
Thus, great care in study design and analyses should be taken when investigating future
relationships on telomere length among different race/ethnicities.
3. Modifiable Determinants of Telomere Length
a. Overview
Telomere length is genetically determined (Vasa-Nicotera et al., 2008); however,
telomere attrition has been associated with many environmental and lifestyle factors,
including obesity (Revesz, Milaneschi, Verhoeven, Lin, & Penninx, 2015), low physical
activity (Cherkas et al., 2008), poverty and educational status (Arline T. Geronimus et al.,
2015), stress (Epel et al., 2004), and smoking (Huzen et al., 2014). Shorter telomere
length has also been associated with chronic disease states such as cardiovascular disease
(Fitzpatrick et al., 2007), hypertension (Samani, Boultby, Butler, Thompson, & Goodall,
2001), type 2 diabetes (Willeit et al., 2014; Zhao et al., 2014), Alzheimer’s disease
(Panossian et al., 2003), and certain cancers (Willeit et al., 2010) independent of
chronological age. The disputable issue of whether telomere length is causal or
consequential of aging remains elusive. Nonetheless, evidence indicates that telomere
length is a key trademark of aging (López-Otín, Blasco, Partridge, Serrano, & Kroemer,
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2013). An observation that has paved the way for its use in epidemiological research
investigating the role of telomere length in predicting disease and mortality, as well as
whether it can be altered by lifestyle and dietary modifications.
b. Physical Activity
Environmental and lifestyle factors have been investigated for their association
with telomere length in numerous studies. Research supports the role of physical activity
(PA) and numerous health benefits. Thus, a positive association between PA and
telomere length has been proposed (Cherkas et al., 2008). In an effort to critically assess
the data on PA and telomere length, a systematic review and meta-analysis on the subject
was conducted (Mundstock et al., 2015). The authors included 37 original studies in the
systematic review (n=41,230), and 25 had sufficient data to be included in the metaanalysis, 11 of which specifically evaluated the correlation between the level of PA and
telomere length. Of the 37 studies in the systematic review, 15 demonstrated a positive
association between reported PA and telomere length, 14 of which were significant. The
authors state that based on their results, there was not enough good-quality evidence to
clearly establish an association between PA and telomere length. The meta-analysis
demonstrated a difference in the standard means between the active and inactive groups
of 0.91 (95% CI 0.48-1.35) in favor of the active group, however, this was not
statistically significant. This systematic review and meta-analysis was limited primarily
due to the moderate quality and methodological limitations of the included studies. There
was high heterogeneity in the meta-analysis likely due to the differences in
methodological techniques including measurement of telomere length, lack of controls,
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poor information on potential confounding variables, and the instruments used in
determining the level of PA (Mundstock et al., 2015).
c. Obesity
To assess the effects of obesity on telomere length, investigators screened 789
potential unduplicated articles and conducted a systematic review and meta-analysis on
the data. Of these, 716 studies were excluded for various reasons including missing data
and not meeting inclusion criteria. Sixty-three studies were included with data on 119,439
participants. Of the studies examined, 24 did not find significant results, while the
remaining 39 found a statistically significant association between obesity and telomere
length (38 of which had an inverse relationship). The meta-analysis of studies reporting
an association between body mass index (BMI) and telomere length yielded a trend for a
weak inverse correlation. As in the previous systematic review on physical activity, this
study also reported high heterogeneity indicating the results should be considered with
caution. The question on a causal relationship between obesity and telomere length
remains elusive.
d. Smoking
Poorer health outcomes have long been attributed to smoking status. In the mid1980’s Nakayama et al. noted that smoking resulted in single-strand breaks in human
DNA (Nakayama, Kaneko, Kodama, & Nagata, 1985). In a recent paper, investigators
looked at the effects of smoking as well as other metabolic traits (waist circumference,
cholesterol levels, blood glucose levels, and blood pressure) on telomere length. Active
smoking increased the yearly telomere attrition rate by more than three-fold (Huzen et al.,
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2014). The authors also mention that for subjects who were former smokers, their
annual attrition rate was comparable to subjects who never smoked.
In addition to smoking, the authors found evidence supporting longitudinal
associations between accelerated telomere loss and high blood pressure, elevated glucose
levels and increased waist circumference (Huzen et al., 2014). These findings support the
hypothesis that certain modifiable lifestyle factors impact the speed of biological aging
and could provide a plausible mechanistic link to many age-associated diseases. Future
prospective research is needed to determine if modifying telomere length could influence
healthy aging and the associated disease states.
e. Indicators of Socioeconomic Status
As with other environmental factors, previous studies have shown an association
between indicators of socioeconomic status (SES) and morbidity and mortality (Adler &
Rehkopf, 2008). SES is often measured via numerous indicators such as education,
income, social class, and occupation, depending on the available data, research question,
and/or geographical location (Robertson et al., 2013). These assessments are considered
broad indicators of SES and often used interchangeably. Education, however, has been
hypothesized as being a better indicator of SES in adulthood, and thus a superior marker
for identifying an association between SES and telomere length. Effects of SES on
telomere length may take years to accumulate; therefore, education may best represent
the time during early adult life through middle age more so than present day indicators
(Steptoe et al., 2011).
Several studies have investigated the association of telomere length and indicators
of SES. In one study, researchers examined 70 children (35 white, 35 black) with ages
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ranging from 7 to 12.6 years, who were randomly selected from a larger pool of 360
children (120 white, 120 black, 120 Latino) (Needham, Fernandez, Lin, Epel, &
Blackburn, 2012). SES measures included parental education level and household
income. Children living in the lowest income households (<$40,000/year) tended to have
a lower T/S ratio compared to children living in the highest income families
(≥$70,000/year) (β = -0.38; 95% CI: -0.82, 0.06; p = 0.09) (Needham et al., 2012).
Needham and colleagues also utilized data from the National Health and Nutrition
Examination Survey (NHANES) and investigated the association between SES, health
behaviors and telomere length (Needham et al., 2013). The authors used education level
and household income as indicators for SES, as well as BMI, smoking, alcohol and
physical activity (PA) as indicators for health behaviors. Telomere lengths of respondents
who did not graduate from high school were approximately 4% shorter than those who
graduated from college (p<0.01) (Needham et al., 2012). This corresponded to a
difference of 102 base pairs (bp), which given the model-based estimate of ageassociated telomere shortening of 14.6 bp/year, was roughly equivalent to seven years of
additional aging. The authors found no association between income and telomere length.
Despite the association found from this large, nationally representative sample, a
systematic review and three separate meta-analyses of 29 unique studies found no
evidence for an association between SES and telomere length. However, the metaanalysis on education confirmed that high (compared to low) education was weakly
associated with longer telomere length (Robertson et al., 2013). Notably, there was
significant heterogeneity among the studies. Although these analyses provide an
indication to support a positive relationship between education and telomere length, they
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fail to provide conclusive evidence of an association between all SES indicators and
telomere length, warranting further investigation.
f. Stress and Mental Health
Epidemiological studies have investigated an association between stress and
chronic mental states, such as depression and anxiety disorders, as well as, cardiovascular
disease and type 2 diabetes. Data from the 1999-2002 cycles of NHANES yielded an
association between telomere length and mental health disorders (Needham et al., 2015).
After controlling for age, gender, and race/ethnicity, no associations between depression
or anxiety status and telomere length were found in a sample of 1,164 participants. When
stratified on gender (a known confounding variable), generalized anxiety disorder / panic
disorder was significantly associated with shorter telomere length in women (β: -0.26),
but not in men (β: -0.00). In addition, the researchers found that severe depressive
symptomatology (identified by antidepressant use) was associated with shorter telomere
length even in early adulthood. The authors state that their study was marginally
underpowered (Needham et al., 2015).
Investigators of another study looked at the association of racial discrimination
and mental health on telomere length in a sample of 95 African American men (Chae et
al., 2016). After controlling for sociodemographic factors, greater anxiety symptoms
were associated with shorter telomere length (β: -0.29, SE = 0.014, p <0.05). In addition,
there was a significant interaction between racial discrimination and depression
predicting telomere length with reported racial discrimination being associated with
shorter telomere length among those with lower levels of depressive symptoms (β: 0.011,
SE = 0.005, p <0.02). As hypothesized, participants reporting low levels of racial
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discrimination along with lower levels of depressive symptoms, had a longer mean
telomere length (Chae et al., 2016).
g. Oxidative Stress
Of the proposed mechanisms relating stress and overall health, alterations in the
hypothalamic-pituitary-adrenal (HPA) axis and the immune system are of relevant
interest as inflammation is a key biological mediator of morbidity and mortality.
Inflammation is known to trigger T-cell proliferation, which is linked to telomeric
shortening (Kiecolt-Glaser et al., 2013). Inflammation can also result in oxidative stress,
defined as “a disturbance in the balance between the production of reactive oxygen
species (ROS) and antioxidant defenses” that may lead to tissue injury (Betteridge, 2000).
Production of ROS, such as the hydroxyl radical (●OH) and superoxide anion (O2●-), is an
unavoidable circumstance of the body’s biochemical processes. These free radicals are
unstable due to the presence of unpaired electrons and can start a chain of events
ultimately leading to cell damage. Antioxidant defenses are the body’s primary protection
against tissue injury. Chronic low levels of oxidative stress can cause DNA damage,
resulting in single-strand breaks (Petersen, Saretzki, & Zglinicki, 1998). Telomeres are
particularly susceptible to oxidative damage given their guanine-rich ends (Von
Zglinicki, 2002). This author noted that the loss of protective telomeres may result in
chromosome instability, fusion with neighboring chromosomal ends and double-strand
breaks in DNA.
A reduction in oxidative stress leads to a decreased rate of telomeric shortening
and postponement of cell senescence (Sitte, Saretzki, & Von Zglinicki, 1998). As both an
indicator of oxidative stress and cell senescence, telomere length has emerged as a
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potential biomarker of biological, as well as functional aging. Dysfunctional telomeres
are linked to development of chronic pathologies including cardiovascular disease, type 2
diabetes, hypertension, Alzheimer’s disease and certain cancers (Paul, 2011).

B. Health Outcomes and Telomere Length
1. Cardiovascular Disease
A systematic review and meta-analysis was conducted investigating telomere
length and risk of cardiovascular disease (CVD) (Haycock et al., 2014). The authors
focused on prospective and retrospective studies involving coronary heart disease (CHD)
and/or cerebrovascular disease. In all, 24 studies (12 prospective, 12 retrospective)
involving 43,725 participants (8400 with CVD) were investigated. The heterogeneity in
telomere length were reported to be attributable to the quality, size, and age variability.
The pooled relative risk (RR) for CHD comparing the subjects with the shortest third of
telomere length to the subjects in the group with the longest third of telomere length was
1.54 (95% CI: 1.30, 1.83; 20 studies) with moderate heterogeneity (I2 = 64%) (Haycock
et al., 2014). Additionally, the pooled RR for cerebrovascular disease for shortest third
vs longest third of telomere length using information from 10 studies (4 retrospective, 6
prospective) after adjusting for multiple factors was 1.42 (95% CI: 1.11, 1.81) with no
significant heterogeneity present (Haycock et al., 2014).
Results from this meta-analysis indicate an inverse association between telomere
length and risk of CHD independent of conventional vascular risk factors. The
association between telomere length and cerebrovascular disease was comparable;
however, it was not significant in the meta-analyses restricted to the prospective studies
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or the higher quality studies. The authors indicated further well-designed, prospective
studies are warranted to determine causality. They speculate that one mechanism for a
causal association between shorter telomeres and increased CVD risk could be the
accumulation of senescent cells, which are a prominent feature of atherosclerotic plaque.
This cell accumulation promotes apoptosis, which can further exacerbate inflammation
and endothelial dysfunction (Haycock et al., 2014).

2. Type 2 Diabetes Mellitus
Data from the Danish Twin Registry was used to investigate the association
between development of insulin resistance and telomere length (Verhulst et al., 2016).
The authors analyzed data from 338 same-sex twin pairs who participated in a 12-year
longitudinal study on cardiovascular risk factors. Plasma glucose, cholesterol and
triglyceride levels, and serum insulin were measured, and HOMA-IR was calculated as a
measure of insulin resistance. Baseline insulin resistance was not associated with
telomere length attrition at follow-up; however, shorter telomere length at baseline was
associated with an increased development of insulin resistance at follow-up (p<0.0001).
These data support the hypothesis that those who have a shorter telomere length in young
adulthood may be more susceptible to developing insulin resistance and conceivably type
2 diabetes at a younger age compared to their peers with a longer telomere length.
Similar results were found from a prospective cohort of 2,328 Native Americans,
a population with a disproportionately high prevalence of diabetes (Zhao et al., 2014). At
baseline, diabetic participants had a significantly shorter mean telomere length, higher
body mass index (BMI), larger waist circumference (wc), higher systolic blood pressure,
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higher triglycerides, and higher highly-sensitive C-reactive protein (hsCRP). After
adjusting for age and other covariates, the inverse associations between telomere length
and BMI (r=-0.121), wc (r=-0.154), and hsCRP (r=-0.089) remained significant (Zhao et
al., 2014).
Among the 2,328 initially non-diabetic participants, 292 developed type 2
diabetes (T2DM) at the end of the five-year follow up (12.5%). After adjusting for
covariates, those that developed T2DM had a significantly shorter mean telomere length
at baseline (mean T/S ratio 0.96 vs. 1.02) compared to those who remained free of the
disease (p = 0.007). Adjusted cox spline regression analysis, using telomere length as a
continuous variable, indicated that a longer mean telomere length was significantly
associated with a reduced risk of T2DM (β = -2.78; HR 0.06 [95% CI: 0.01, 0.42],
p=0.004) (Zhao et al., 2014). The results demonstrated that those in the shortest quartile
for telomere length had a nearly two-fold increased risk of developing T2DM compared
to the those in the longest quartile (HR 1.83 [95% CI: 1.26-2.66], p<0.0001) (Zhao et al.,
2014).
In a separate prospective study, 1000 participants were followed every five years
for 15 years, with a 90% participation rate (Willeit et al., 2014). Leucocyte telomere
length from three time points were collected and analyzed (1995, n=684; 2005, n=558;
2010, n=479). Of the 606 participants who were free of T2DM at the start of the study, 44
went on to develop the disease (7.3%). The authors reported an adjusted hazard ratio
(HR) for T2DM of 2.00 (95% CI: 0.90, 4.49; p = 0.091) comparing the shortest telomere
length quartile to the longest. When combining the top three quartiles and comparing
them to the shortest, they reported a HR of 2.31 (95% CI: 1.21, 4.41; p = 0.011) (Willeit
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et al., 2014). The authors also conducted a literature-based meta-analysis of three relevant
prospective studies, including the previously discussed study by Zhao and colleagues.
The pooled studies included 6,991 participants and 2,011 incident cases of T2DM. The
pooled RR for comparison of the shortest telomere length quartile at baseline with the
longest was 1.31 (95% CI: 1.07, 1.60; p=0.01; I2 = 69%) (Willeit et al., 2014). The
authors report that shorter relative telomere length is independently associated with the
increased risk of T2DM; however, a causal involvement of telomeres in the disease
development remains elusive (Willeit et al., 2014).
3. Cancer

Attention was given to a 2009 publication by Hou et al. for their proposition that
shortened telomere length is a risk factor for gastric cancer (Hou et al., 2009). The
authors conducted a population-based case-control study in Warsaw, Poland between
1994 and 1996. Telomere length was measured using quantitative real-time polymerase
chain reaction (qPCR) in 300 cases of gastric cancer and 416 age- and sex-matched
controls, investigating the association between telomere length and risk of gastric cancer,
as well as confounders and risk modifiers for telomere length-related risk. Data on
education level, BMI, smoking status, alcohol intake, calorie intake, dietary patterns
including fruit and vegetable intake, red meats, sausage, and preserved vegetables, as
well as H. pylori infection status and familial history of cancer were included in the
analyses.
As expected, when compared to the controls, cases had lower levels of education,
drank more alcohol, smoked more cigarettes, consumed fewer vegetables, and had greater
familial history of gastric cancer. With regards to telomere length, cases of gastric cancer
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had significantly shorter telomere length compared to controls. Unconditional logistic
regression analysis of telomere length in quartiles, demonstrated that the risk of gastric
cancer was doubled for cases in the lowest quartile of telomere length compared to those
in the highest quartile (OR=2.04; 95%CI: 1.33, 3.13) even after adjusting for many
potentially confounding factors (Hou et al., 2009).
A similar study was conducted investigating telomere length and risk of gastric
cancer (Liu et al., 2009). The authors reported that after adjusting for confounding
factors, individuals with a shorter telomere length had a two-fold increased risk of gastric
cancer (OR = 2.14, 95% CI: 1.52, 2.93) (Liu et al., 2009). The authors also observed a
dose-response relationship with risk of gastric cancer within the quartiles of telomere
length. With the lowest quartile being the referent group, the second, third, and fourth
quartiles had a subsequent increased risk of gastric cancer with an OR of 1.45 (95% CI:
0.97, 2.23), 2.11 (95% CI: 1.36, 3.24), and 3.12 (95% CI: 2.01, 4.79), respectively (Liu et
al., 2009). The results of these two studies on telomere length and gastric cancer are in
agreement with other studies of telomere length and cancer, including cancers of the
bladder (Broberg, Björk, Paulsson, Höglund, & Albin, 2005; McGrath, Wong, Michaud,
Hunter, & De Vivo, 2007), lung (Jang et al., 2008), kidney (Pal et al., 2015), and
pancreas (Skinner et al., 2012).
Among renal cell carcinoma (RCC) cases, data suggested significantly shorter
telomere lengths within the RCC tissue compared to normal adjacent renal tissue from
the same subject (p = 0.000) (Pal et al., 2015). Low grade tumors (grades I & II) had
significantly longer telomere lengths than high grade tumors (grades III & IV) (p=
0.016), indicative of extensive cell proliferation. The authors suggest their findings
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support the view that shorter telomere length is in part, responsible for early development
and aggressiveness of the tumor, and that telomere length and telomerase activity can be
used as predictive and diagnostic markers of cancer (Pal et al., 2015).
A U-shaped phenomenon has also been observed in studies investigating telomere
length and cancer. Data from a case-control study on telomere length and gastric cancer
risk in a Chinese population demonstrated an increased risk of gastric cancer associated
with both shorter and longer telomere lengths (Du et al., 2015). The study population
consisted of 1136 cases of gastric cancer along with 1012 age- and gender-matched
cancer-free controls. The researchers separated the groups into a quintile distribution of
relative telomere length (RTL) for analyses. The first quintile contained those with the
longest RTL, while the second quintile was the referent group. There was a doseresponse increased risk of gastric cancer observed in the third, fourth, and fifth groups
with odds ratios of 1.28 (95% CI 0.93, 1.77), 1.65 (95% CI: 1.21, 2.26), and 3.81 (95%
CI: 2.82, 5.13), respectively when compared to the referent group (Du et al., 2015).
Interestingly, the first quintile, those with the longest RTL, had an OR of 1.78 (95% CI:
1.30, 2.44). Thus, a near two-fold increased risk of gastric cancer was found among those
with the longest telomere length (Du et al., 2015).
U-shaped results have also been reported in other studies involving telomere
length and cancer. Investigators observed a linear trend for a higher risk of pancreatic
cancer associated with a shorter mean telomere length where the overall result was a
skewed U-shaped relationship between telomere length and prevalence of pancreatic
cancer (Skinner et al., 2012).
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Other studies have reported finding associations of longer telomere length with
cancer. Investigators conducted a case-control study in women looking at telomere length
and risk of breast cancer among 265 cases and 446 controls (Svenson et al., 2008). Blood
cell telomeres were longer in the cases compared to the controls. In determining
associated risk of breast cancer, the groups were divided into quartiles based on relative
telomere length (RTL) distribution among the controls. Breast cancer risk increased in
the second, third, and fourth quartiles compared to the referent group (Ptrend < 0.001),
with an OR of 5.17 (95% CI: 3.09, 8.64) in the quartile with the longest telomeres
(Svenson et al., 2008). The researchers also examined RTL as a predictor of survival. The
cases were dichotomized into two groups based on the median RTL value of 0.73.
Patients under 50 years of age with shorter telomeres had a significantly better outcome
than patients with telomeres longer than the median value (p = 0.024). For patients 50
years and older, a borderline value was observed (p = 0.095). Overall, the investigators
determined that RTL was found to represent a strong independent prognostic indicator in
patients with advanced breast cancer.

4. Alzheimer’s Disease and Cognitive Decline
Cognitive decline, including dementia and Alzheimer’s disease, is highly
associated with the aging process and is significantly modified by genetic and
environmental factors. A study in a cohort of elderly Chinese men looked at telomere
length and cognitive function (Ma et al., 2013). The 976 participants were originally
recruited for a health survey in Hong Kong between 2001 and 2003 where they were

20

screened for cognitive function via the Mini-Mental State Examination (MMSE), as well
as the Community Screening Interview for Dementia.
Participants were divided into tertiles based on mean telomere lengths of short
(7.20 kb, n = 335), medium (8.85 kb, n = 369) and long (11.00 kb, n = 251). No
association was found between telomere length and MMSE score; however, subjects in
the medium and long telomere length groups performed significantly better in the
episodic memory challenge (r=0.086, p=0.007), as well as the executive function measure
of verbal fluency (r=-0.053, p=0.048) after adjusting for age and education level (Ma et
al., 2013).
When subjects were divided by MMSE score using the accepted cutoff for
cognitive impairment (>24 vs ≤ 24), those below the cutoff had a mean telomere length
251 base pairs (bp) shorter than those with an MMSE score above the cutoff (p = 0.04).
Additionally, when results from the three exams were combined, participants with all
three test scores above the cutoff had a significantly longer mean telomere length (9.03
kb, n=244) compared to those with no scores above the cutoff (8.67 kb, n=52) (Ma et al.,
2013). Notably, this study failed to control for potential factors associated with the
outcome including BMI, co-morbidities, and smoking status.
In a longitudinal study from the Lothian Birth Cohorts 1936 and 1921, data were
used to investigate telomere length and cognitive decline later in life (Harris et al., 2016).
Blood samples, as well as physical and cognitive exams were collected and analyzed at
multiple timepoints throughout the study. Quantitative PCR was used to analyze telomere
length. Linear mixed models were used to investigate change in telomere length,
cognitive function and physical ability over time. In both cohorts, there was an overall
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decrease in telomere length with age. Interestingly in both cohorts, telomere length was
longer in males than in females (LBC1936 by 177.9 bp; LBC1921 by 256.9 bp). This
finding is contrary to most data available on sex and telomere length (Gardner et al.,
2014). There was no evidence to indicate that baseline telomere length was associated
with the course of physical and/or cognitive decline. Thus, the rate of telomere length
decline did not correlate with the rate of decline in physical and/or cognitive function.
The longitudinal design adds strength to the results. The investigators were able to
utilize multiple time points throughout the duration to measure telomere length in aging
adults. Nevertheless, this study experienced loss to follow up due to natural attrition in
these aged cohorts (retention of 64% and 11%, respectively). The authors neglected to
mention the possibility of survival bias, which may have impacted their findings and
nullified their results.

C. Micronutrients and Telomere Length
1. Overview of Dietary Intake and Telomere Length
It is well known that numerous dietary factors influence the risk of chronic
disease, but the mechanisms of action by which micronutrients influence chronic disease
outcome are complex and uncertain in most cases. Moreover, little is known about the
association of telomere length and micronutrient status in adults. In a study of 56 middleaged Italian subjects, Marcon and colleagues found a significant correlation between
mean telomere length and dietary intake of micronutrients, based on a food frequency
questionnaire (FFQ) developed for Italian dietary habits (Marcon et al., 2012). The
authors reported that vegetable intake was significantly and positively associated with
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mean telomere length after adjusting for age (p=0.013), with strong associations also
found among the antioxidants beta-carotene (p=0.001), vitamin A (p=0.001), vitamin C
(p=0.016), vitamin E (p=0.014), as well as folic acid intakes (p=0.019) (Marcon et al.,
2012). In this study, the term folic acid was used to represent folate for which intake was
determined based on consumption of dark leafy greens, categorized as “spinaches” by the
researchers. Currently, cereal grains are not fortified with folic acid in Italy, and only a
limited number of commodity items available, such as corn flakes, have been fortified
with folic acid.
Interestingly, when the women were dichotomized on age (above and below the
mean age of 56 years), beta-carotene appeared to be protective against telomere attrition
only in the younger women (p=0.009) (Marcon et al., 2012). This observation supports
the role of dietary factors, specifically antioxidants, in diminishing oxidative damage to
telomeres in younger individuals. Notably, this study did not investigate biomarkers for
any of the micronutrients. Nonetheless, the authors referenced a study which found a
significant correlation between the dietary FFQ used and blood micronutrient levels.
However, the use of “spinaches” as a dietary marker of folate intake alone is limiting.
Dark leafy greens are rich in numerous micronutrients and phytochemicals. The
possibility remains that the correlation between “folate” intake and telomere length
proposed by the authors may be due to other nutritive components in the dark leafy
greens, and not limited to folate itself.
In another study, Xu et al. investigated multivitamin use and telomere length in
586 women 35 to 74 years of age (2009). The authors reported that in general,
multivitamin use was associated with longer telomere length, and compared to non-users,
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daily users had on average 5.1% longer telomeres (Ptrend = 0.002). Statistically, this
difference corresponded to approximately 9.8 years of age-related telomere loss. Once-aday multivitamins and the antioxidant combination supplements were also significantly
associated with telomere length (Ptrend = 0.01, Ptrend = 0.009, respectively); however, the
authors found no association between the Stress-tabs or B-complex use category and
telomere length (Ptrend=0.5). When individual micronutrient supplements were
investigated, only vitamin B12 and iron use demonstrated significant findings. Vitamin
B12 users (n = 52) had significantly longer telomere lengths (p = 0.03) compared to nonusers of vitamin B12 supplements (n = 518). In addition, iron users (n=41) had
significantly shorter telomere lengths (p = 0.007) compared to non-users of iron
supplements (n = 527). Although most micronutrient intakes from food in the Xu study
were positively associated with telomere length, most became nonsignificant when
adjusted for multivitamin use. Nonetheless, among the women who did not use
multivitamins (n = 203), higher dietary intakes of beta-carotene (p = 0.045), folate (p =
0.02), magnesium (p = 0.04), vitamin C (p = 0.002), vitamin A (p = 0.008), and vitamin E
(p = 0.03) were significantly associated with longer telomere length (Xu et al., 2009).
Similarly, Garcia-Calzon and associates reported diets higher in antioxidants were
significantly associated with longer telomere length (García-Calzón, Moleres, et al.,
2015). The authors demonstrated that dietary total antioxidant capacity (TAC) was
positively correlated with longer telomere length in Spanish children ages 6 to 18 years (p
= 0.007) after adjusting for covariates. In addition, higher intakes of legumes and PUFAs
were positively associated with longer telomere length (p = 0.032 and p = 0.019,
respectively), while diets higher in cereals and white bread were significantly associated
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with shorter telomere length (p = 0.002 and p = 0.002, respectively), even after adjusting
for potential confounders (García-Calzón et al., 2015).
2. Iron Status and Telomere Length
The average human body contains approximately two to four grams of iron.
Although iron is found in numerous food sources, the typical American diet consists of
only five to seven mg/1000 kcal in both a heme and nonheme form. Heme iron is that
which is bound to the porphyrin ring structure and derived from hemoglobin and
myoglobin sources found in animal products. Nonheme iron is sourced primarily from
plant foods including leafy greens, nuts, legumes, grains, fruits and vegetables (Gropper,
Smith, & Groff, 2009a).
Digestion and absorption of the two forms differ; thus, dietary intakes and
restrictions can substantially influence iron stores. Heme iron is first hydrolyzed in the
stomach and small intestine to release the heme-porphyrin ring (also known as
metalloporphyrin) from the globin complex. Heme is readily absorbed across the brush
border of the enterocyte by a heme carrier protein (hcp1), primarily in the duodenal
region of the small intestine.
Nonheme iron must be enzymatically released from food to be absorbed. Most
nonheme iron from plant sources is in the ferric (+3) form, which is soluble under acidic
conditions, such as in stomach acid. However, once chyme passes into the small intestine,
the alkaline pancreatic secretions may cause ferric iron to form ferric hydroxide
(Fe(OH)3), an insoluble, less bioavailable iron complex. Ferrireductases, such as Dcytb,
on the brush border in the duodenum function to reduce ferric iron to the more soluble
ferrous state. Vitamin C appears necessary for the reductase activity. Ferrous iron from
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nonheme sources crosses the brush border via the divalent mineral transporter 1 (DMT1)
in the duodenal portion of the small intestine. DMT1 also transport other minerals such as
zinc, manganese, copper, nickel, and lead.
Within the enterocyte, ferrous iron (Fe+2) binds to compounds (chelators and
ligands) which determine iron’s fate depending on the binding nature of the
chelator/ligand. Iron can be used by the mucosal wall, sloughed off within the cell and
excreted into the feces, or transported out and used by other body tissues. Absorption
enhancers for nonheme iron include sugars, such as fructose, acids, such as citric acid and
ascorbic acid, as well as products of meat digestion. Dietary factors inhibiting nonheme
iron absorption include polyphenols (tannin derivatives), oxalates from foods such as
spinach, berries and chocolate, phytates from corn, whole grains and legumes, as well as
other minerals including calcium, zinc and copper (Gropper et al., 2009a).
Nearly 65% of iron in the body is associated with hemoglobin; however, the
importance of iron extends well beyond its oxygen carrying ability. The remaining iron is
stored in hepatocytes as ferritin and hemosiderin (as Fe+3), or in the spleen, bone marrow,
and/or muscle tissue, as well as being a part of enzymes. Iron is involved in numerous
metabolic processes as a part of heme in a cluster with sulfur, or by itself. It functions as
a component of proteins involved in DNA synthesis, such as ribonucleotide reductase,
and part of the catalytic site of cytochromes and peroxidases. Iron also acts as a cofactor
for dozens of enzymes, including the reactive oxygen species (ROS) quenching enzymes
catalase and myeloperoxidase (Gropper et al., 2009a).
Reactive oxygen species such as the superoxide radical (O2●), hydroxyl radical
(●OH), and hydrogen peroxide (H2O2) are generated in the body and are typically
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quenched by antioxidants and/or enzymes. However, a disruption in the equilibrium and
subsequent ROS overload, can result in oxidative damage. Ferric iron (Fe+2) is released in
high concentrations from lysosomal apoptosis resulting from the cell damage. This
excessive free ferrous iron can be a catalyst for further reactions (i.e., Fenton reaction)
from which ROS are formed; thus perpetuating the cycle and leading to oxidative stress
(Kepinska, Szyller, & Milnerowicz, 2015).
Antioxidants appear to have a protective effect and have been associated with
longer telomere length (García-Calzón et al., 2015; Xu et al., 2009). Iron has the unique
properties of being involved in both anti-oxidative and pro-oxidative reactions (Pra,
Franke, Henriques, & Fenech, 2012). It is also a key trace element in nucleic acid
metabolism, including nucleotide synthesis, as well as DNA synthesis and repair (Pra et
al., 2012). Iron is a co-factor in DNA polymerases, DNA helicases, and the DNA primase
regulator subunit PRIM2 (Zhang, 2014). Iron deficiency, as well as iron overload, is
associated with genomic instability. Iron deficiency anemia increases nuclear DNA
damage in adults (Zhang, 2014). Thus, both conditions have the potential to have a
detrimental effect on telomere length. To our knowledge, no study has investigated the
impact of iron deficiency on telomere length.
a. Iron Status and Telomere Length
The findings on iron supplementation by Xu et al. (Xu et al., 2009) were in
agreement with data reported by Mainous and colleagues in which elevated serum
biochemical tests of iron status were significantly associated with shorter telomere
lengths (p < 0.0001), likely due to the highly oxidative nature of iron (Mainous III et al.,
2013). From the available data on 511 men and women, the authors investigated both
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phenotype (serum ferritin >1000 ng/mL) and HFE genotype (gene for hemochromatosis)
markers of iron status. The researchers found that an elevated iron phenotype, but not
hemochromatosis genotype, was significantly associated with a shorter telomere length in
both the crude and adjusted models (Mainous III et al., 2013).
Furthermore, in a subsequent study by Mainous et al. (2014), investigating iron
status, telomere length and quality of life in 669 participants, the researchers reported that
in the unadjusted model, overall general health (p<0.001) and mental health (p<0.01)
statuses were significantly worse among those with elevated transferrin saturation
percentage (TS%) (≥50% for men, ≥45% for women) compared to non-elevated TS%
(<50% for men, <45% for women). Additionally, telomere length was significantly
shorter (p<0.01) in those with elevated TS% compared to the non-elevated TS% subjects.
After adjusting for demographics and socio-economic status, those with elevated TS%
had poorer mental health status and shorter telomere length compared to the non-elevated
TS group, (p<0.001 and p<0.01, respectively). In the fully adjusted model (additional
adjustments for chronic disease states), significantly poorer mental health status remained
among those in the elevated TS% group (p<0.0001), as was a trend toward shorter
telomere length (p<0.05) (Mainous III et al., 2014).
Kozlitina and colleagues investigated the association of parameters of red blood
cell size and telomere length in a cohort of 3,157 individuals (Kozlitina & Garcia, 2012).
After adjusting for potential confounding variables (age, gender, and ethnicity), the
investigators found a strong, significant association between the size of the red blood cell
measured by mean corpuscular volume (MCV), as well as the RBC distribution width
(RDW), and a shorter mean telomere length (p<0.0001, p<0.0001, respectively). In
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addition, they observed that higher hemoglobin levels were also associated with shorter
telomere length (p=0.0009) in this population. However, contrary to the findings by
Mainous et al. (2014), the authors did not find an association between telomere length
and iron stores. Although the authors do not speculate, it is well known that iron, as well
as, vitamin B12 and folate are key micronutrients involved in red blood cell (RBC)
production. Thus, higher hemoglobin could potentially correlate with elevated iron in the
erythrocyte, just as elevated MCV and RDW correlate with vitamin B12 and folate
deficiency (Kepinska et al., 2015).
It is well understood that an insufficiency of vitamin B12 and/or folate can result
in macrocytic red blood cells, identified hematologically by elevated MCV and RDW.
While the authors reported an association between elevated MCV, greater RDW and a
shorter telomere length, they did not investigate the status of other micronutrients
involved, such as vitamin B12 and folate (Kozlitina & Garcia, 2012). Interestingly,
homocysteine levels were higher in the shortest tertile of telomere length compared to the
longest (p=0.0054); however, after full adjustment, the association lost significance.
Homocysteine is known to be elevated in both folate and vitamin B12 deficiency. This
study demonstrated strength in sample size, although it was limited by design having
originated as a cross sectional study in 2000, and later transformed to a longitudinal study
in 2007 (Kozlitina & Garcia, 2012).
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3. Factors in One-Carbon Metabolism
a. Overview
The requirement of vitamin B12 for folate metabolism has been well established.
Vitamin B12 in the form of methylcobalamin serves as a coenzyme in the conversion of
homocysteine to methionine (Fig.1). The formation of methylcobalamin requires a
methyl group from folate in the form of 5-methyl tetrahydrofolate (5-MTHF). The
enzyme Methionine Synthase bound to cobalamin picks up the methyl group from 5MTHF forming methylcobalamin and tetrahydrofolate (THF). In this process, the methyl
group from the newly formed methylcobalamin is transferred to homocysteine converting
it into methionine. The formation of 5-MTHF is irreversible, thus a deficiency in vitamin
B12 traps folate in this methylate form, commonly referred to as the “methyl-folate trap.”
With adequate vitamin B12 status, folate as THF, is available as a substrate for its other
coenzyme forms such as, 10-formyl THF which is required for purine synthesis, and
5,10-methylene THF required for thymidylate synthesis essential for DNA synthesis
(Gropper, Smith, & Groff, 2009b).
Homocysteine (Hcy) is a non-protein forming amino acid that acts as a methyl
carrier in folate metabolism. After synthesis, methionine is activated by ATP to form Sadenosylmethionine (SAMe) which serves primarily as a universal methyl donor in
numerous reactions throughout the body. The post-methylation byproduct, Sadenosylhomocysteine (SAH), is subsequently hydrolyzed to Hcy. Homocysteine is then
ready to accept another methyl group from the Methionine Synthase–Vitamin B12
complex and repeat the cycle. Via a transsulfuration pathway, catalyzed by cystathionine
β-synthase requiring pyridoxal-5’-phosphate (PLP), homocysteine irreversibly condenses
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with serine to form cystathionine which is further hydrolyzed by a second PLP-dependent
enzyme, gamma-cystathionase, to form cysteine and α-ketobutyrate.
Elevated blood Hcy, or hyperhomocysteinemia, has long been considered a risk
factor for deleterious health outcomes, particularly cardiovascular disease (Reynolds,
2006). Much research on this subject culminated in a prominent meta-analysis in which
included 27 studies involving over 4,000 patients with occlusive vascular disease
(including cardiovascular, peripheral, and cerebrovascular), and over 4,000 healthy
controls (Boushey, Beresford, Omenn, & Motulsky, 1995). Data showed that Hcy was an
independent risk factor for atherosclerotic vascular disease, specifically, of the coronary,
cerebral, and peripheral vessels.
Subsequent studies have gone on to further demonstrate an indisputable link
between elevated Hcy and an increased risk of disease. One study out of the Framingham
Heart Study showed that among 1933 elderly subjects, those with elevated Hcy (upper
quartile) had a greater than two-fold increase in all-cause cardiovascular disease mortality
compared to those with lower Hcy levels (lower three quartiles) (RR = 2.18; 95% CI:
1.86, 2.56) (Bostom et al., 1999). The association attenuated but remained significant
after adjusting for multiple factors including age, sex, systolic blood pressure, smoking,
diabetes, and cholesterol levels (RR = 1.54; 95% CI: 1.31, 1.82) (Bostom et al., 1999).

b. Folate, Vitamin B12, and Homocysteine
As previously discussed, vitamin B12 is a key nutrient in the methylation of
homocysteine to methionine, and therefore plays an essential role in the reduction of Hcy
levels. With the substantial reduction of folate deficiency following folic acid
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fortification, it remains plausible that prevalent cases of hyperhomocysteinemia are
related primarily to vitamin B12 deficiency, particularly among the elderly who are at the
greatest risk of deficiency due to the higher incidence of pernicious anemia and
malabsorption with increased age.
In a prospective study of 1096 older Latino adults shortly after fortification with
folic acid was in full operation, hyperhomocysteinemia was present in 181 subjects
(16.5%) (Green & Miller, 2005). Of the 181 subjects, 55 (30.4%) had low total vitamin
B12 and/or low holotranscobalamin (holoTC). HoloTC is a vitamin B12/carrier protein
complex and used as a biomarker of B12 status. Thus, holoTC represents the biologically
active fraction of vitamin B12 in the blood, suggesting it may be a more sensitive
biomarker for the vitamin than serum levels alone. Among these 55 participants, 29
subjects were low in both vitamin B12 and holoTC. In contrast, only two (1.1%) of the
181 participants with hyperhomocysteinemia had low RBC folate. Of these two subjects,
both also had low vitamin B12 and/or low holoTC. According to the study, there was an
8-fold risk of hyperhomocysteinemia because of low vitamin B12 (OR=8.3, 95% CI: 4.714.6) and a population attributable risk (PAR%) of 29.7%. The odds for
hyperhomocysteinemia associated with low RBC folate was negligible and nonsignificant
(OR=1.5, 95% CI: 0.2-11.2) and a PAR% of 0.3. Thus, it can be suggested that in the age
of folic acid fortification, hyperhomocysteinemia is more attributable to vitamin B12
deficiency (29.7–36.4%) rather than a deficiency in folate (0.3%) (Green & Miller,
2005).
National Health and Nutrition Examination Survey (NHANES) data from 10,413
participants were analyzed for serum vitamin B12 and folate concentrations, along with
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Hcy and MMA (Selhub, Morris, & Jacques, 2007). Prevalence of vitamin B12 deficiency
(defined as <148 pmol/L) was 1.6% to 2.2% in the NHANES III and 1999-2000 and
2001-2002 cycles, respectively. The mean Hcy level decreased across increasing folate
categories among those with sufficient vitamin B12 levels (≥ 148 pmol/L) in both
NHANES surveys. Contrarily, the mean Hcy level for those who were vitamin B12
deficient increased significantly across the four serum folate categories. Furthermore, the
mean Hcy for the B12 deficient group with serum folate >32.6 nmol/L was nearly 12
µmol/L, a commonly used cutoff point for hyperhomocysteinemia. In addition, among
those with vitamin B12 deficiency in the NHANES 1999-2002 data, serum MMA
concentrations increased significantly across all increasing categories of folate. A
significant decrease in MMA was observed in subjects replete in vitamin B12 (>148
pmol/L) with increasing concentrations of folate (Selhub et al., 2007).
Elevated Hcy is indicative of impaired methionine synthase activity secondary to
vitamin B12 deficiency, whereas high MMA levels reflect compromised methylmalonylCoA mutase activity. These data conclude that both pathways of vitamin B12 metabolism
are adversely impacted by elevated folate concentrations (Selhub et al., 2007). Therefore,
these data suggest that the enzymatic functions of vitamin B12 deteriorate as serum folate
concentrations increase, resulting in elevated MMA and Hcy, the later which is known to
be detrimental to health and well-being (Selhub et al., 2007).
Data from the NHANES 1999-2000 and 2001-2002 cycles yielded an association
between folate and B12 status in relation to anemia (n=1458) and cognitive impairment
(n=1302) in older adults (Morris, Jacques, Rosenberg, & Selhub, 2007). The researchers
defined low B12 status as a serum B12 <148 pmol/L or a serum MMA concentration of
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>210 nmol/L. High folate status was defined as folate concentrations >59 nmol/L.
Within the study population, nearly 3% were B12 deficient (serum B12 <148 pmol/L),
however, 25% met the study criteria for low B12 status. High serum folate concentrations
accounted for 4% of the study population.
In the fully adjusted model, participants with normal B12 status and high serum
folate had a lower prevalence of anemia (OR: 0.6; 95% CI: 0.2, 2.4) and cognitive
impairment (OR: 0.5; 95% CI: 0.2, 0.96) compared to those with normal status in both
nutrients. Among those with low B12 status, those with normal serum folate levels had an
almost 2-fold increased prevalence of anemia (OR: 1.9; CI: 1.01, 3.6) and a trend toward
a 60% increased risk of cognitive impairment (OR: 1.6; CI: 0.95, 2.8) compared to those
with normal status in both nutrients. Moreover, among those with low B12 status and high
serum folate, the risk of anemia and cognitive impairment increased nearly five-fold (OR:
4.8; 95% CI: 2.3, 10.4; OR: 4.9; 95% CI: 2.6, 9.2, respectively) compared to those with
normal status in both vitamins (Morris et al., 2007).
The authors concluded that compared to normal status for both nutrients, high
serum folate status alone was associated with a protective effect for anemia, as well as a
significant reduction in the prevalence of cognitive impairment. On the other hand, low
B12 status regardless of folate status, was associated with a significantly increased risk of
anemia and cognitive impairment. Furthermore, the combination of low B12 status and
elevated serum folate significantly magnified the risk of both conditions (Morris et al.,
2007).
In addition, while elevated homocysteine levels were present in the low B12 / high
folate subjects, the prevalence of hyperhomocysteinemia (>13 µmol/L) in that group was
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significantly lower than that of the group with low B12 status / normal folate (<13
µmol/L) (p <0.001). Hyperhomocysteinemia primarily due to low B12 status, was
associated with an increased risk of both anemia (OR: 2.0; 95% CI: 1.01, 3.8) and
cognitive impairment (OR: 1.9; 95% CI: 1.1, 3.4) in this study (Morris et al., 2007).

4. Factors in One-Carbon Metabolism and Health Outcomes
a. Homocysteine and Cognitive Function
Of unique interest, is the association between hyperhomocysteinemia and
cognitive decline and dementia. In a prospective study looking at homocysteine levels
and risk of dementia and Alzheimer’s disease (AD), participants (n = 1092) from the
Framingham Heart Study were followed for eight years. Of the 111 subjects who
developed dementia, 83 were diagnosed with AD. In the quartile-specific analysis, with
the first quartile of Hcy concentration as the reference, the RR of AD was 1.2 (95% CI:
0.6, 2.2) in the second quartile, 1.3 (95% CI: 0.6, 2.5) in the third quartile, and a RR of
2.2 (95% CI: 1.2, 4.1) in the fourth quartile. In addition, plasma Hcy concentrations
greater than 14 µmol/L, nearly doubled the risk of AD. Moreover, addition of folate,
vitamin B12, and vitamin B6 status to the model did not significantly alter the association,
suggesting Hcy level is a strong, independent predictor of developing AD.
In a recent longitudinal study, researchers investigated the associations between
serum Hcy, vitamin B12 and folate on cognition in the elderly (Hooshmand et al., 2012).
Measurements were taken at baseline in 274 dementia-free participants living in Finland
in 1998. Participants were between the ages of 65 and 79 years of age at the time of entry.
Blood samples were analyzed for total Hcy, serum folate and holoTC, as a biomarker of
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vitamin B12 status. In addition to the biochemical measurements, several
neuropsychological tests were performed to assess cognitive function, including the
Mini-Mental State Examination (MMSE), immediate word recall test, the Stroop test,
category fluency test, and the bimanual Purdue Pegboard test. These exams provided data
which were used to assess global cognition, episodic memory, executive function, verbal
expression, and psychomotor speed both at baseline and at follow up.
Hooshmand et al. (2012) found that elevated Hcy was significantly inversely
correlated with serum folate (r= -0.42) and holoTC (r= -0.46), suggesting that high levels
of Hcy in this study were likely indicative of low folate and low vitamin B12 status. After
adjusting for age, sex, education, follow up time, BMI, blood pressure, smoking status,
APOE-4, and presence of renal insufficiency, elevated Hcy was significantly associated
with declined cognitive function in all areas assessed. With additional adjustments, the
association between Hcy and psychomotor speed lost significance. When adjustments
included serum folate and holoTC, the association between Hcy and MMSE score also
lost significance.
Elevated holoTC at baseline was significantly associated with greater
performance in global cognition (RD = 1.08, 95% CI: 1.00, 1.17), executive function (RD
= 1.13, 95% CI: 1.02, 1.25), and psychomotor speed (RD = 1.18, 95% CI: 1.05, 1.23) at
follow up. When Hcy and folate were included in the model, the trend toward higher
holoTC and improved cognitive performance remained; however, it was no longer
significant. No significant associations between serum folate and the areas of cognitive
function measured were identified (Hooshmand et al., 2012).
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Strengths of this study included the population-based study design and seven-year
follow up time, as well as the use of holoTC as a biomarker of vitamin B12 status.
Limitations included small sample size, availability of serum samples restricted to
baseline collection only, and the lack of other biomarkers for both vitamin B12 and folate
status, including MMA and RBC folate.
In a recent systematic review and meta-analysis of modifiable risk factors
associated with cognition and dementia, investigators included 247 original
epidemiologic studies (167 cohort studies, 80 cross-sectional studies) in their review
(Beydoun et al., 2014). Risk factors included smoking, education, alcohol intake,
physical activity, and Hcy, as well as nutritional factors including caffeine intake, omega3 fatty acids, and antioxidants. Overall, 19 cohort studies investigated Hcy and cognitive
function. Of the 19 studies, 12 found elevated serum Hcy levels to be associated with
poorer cognitive function and/or dementia. Two studies found an association with Hcy
and some cognitive outcomes, but not others, and five studies were unable to detect a
significant association with cognitive function (Beydoun et al., 2014). Homocysteine is
said to have neurotoxic and excitotoxic properties in vitro, proposing a direct effect on
cognitive function (Kruman et al., 2000).
Homocysteine exposure to the primary hippocampal neurons in cultured cells
resulted in apoptosis in a dose-dependent manner (Kruman et al., 2000). DNA strand
breaks occurred rapidly in the neurons exposed to Hcy. Neuronal cells appeared to be
more vulnerable to the effects of Hcy-induced apoptosis compared to other cells
including astrocytes and cultured vascular endothelial cells. Hcy also appears to render
neural cells more vulnerable to oxidative stress and excitotoxicity. The investigators
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tested their hypothesis in vivo by infusing Hcy, alone and with a seizure-inducing
excitotoxin called kainite, into the hippocampus of adult mice. While Hcy alone did not
damage the hippocampal neurons, the combination markedly exacerbated kainite-induced
damage to the pyramidal neurons (Kruman et al., 2000). These and other data
demonstrating that Hcy can sensitize neurons to such adverse conditions, provide insight
into how Hcy might contribute to the pathogenesis of neurodegenerative disorders and
moreover suggest a possible mechanism by which nutrients involved in one-carbon
metabolism may reduce the risk of such disorders.

b. Folate and Cognitive Function
Several studies have investigated the association of serum folate and cognitive
decline (Duthie et al., 2002; Kado et al., 2005; Ramos et al., 2005; Ravaglia et al., 2005).
Ramos et al. examined the association of folate status and cognitive function and
dementia in 1789 community-dwelling elderly Latinos (Ramos et al., 2005). Multiple
linear regression analyses were used to describe the associations between RBC folate
concentration and cognitive function tests in four models before and after adjustment for
serum Hcy, vitamin B12, serum creatinine, and demographics. Cognition was assessed via
six measurements including the Modified Mini-Mental State Examination (3MSE),
delayed recall, object naming, picture association, verbal conceptual thinking, verbal
attention, and pattern recognition. In addition, odds ratios were evaluated as indicators of
the relationship between RBC folate and serum Hcy as independent variables and
diagnostic measures of cognitive decline and dementia. After adjusting for serum Hcy
alone, RBC folate remained inversely correlated with six of the seven cognitive tests. The
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analysis indicated that RBC folate explained 4.0–6.1% (R2 = 0.040–0.061) of the
variance in cognition function scores within the sample. The addition of serum vitamin
B12 and creatinine did not significantly influence the results. However, adding the
demographic variables (age, sex, education, and acculturation) and Center for
Epidemiological Studies Depression Scale (CES-D) score to the model significantly
attenuated the associations. Only the 3MSE and delayed recall remained significant
(p=0.005 and p=0.007, respectively) (Ramos et al., 2005). When evaluating RBC folate
in the secondary analysis, the odds ratio (OR) for low 3MSE (OR = 0.51, 95% CI: 0.32,
0.83) and dementia diagnosis (OR = 0.28, 95% CI: 0.11, 0.72) were significant after
adjusting for all potential confounders. These data indicate that risk of cognitive
impairment and dementia decreased with elevating concentrations of RBC folate (Ramos
et al., 2005).
Folic acid fortification of grains beginning in the late 1990s has significantly
reduced the prevalence of folate deficiency in the United States (defined as plasma folate
<6.8 nmol/L) from 22% to approximately 1.7% of the population, and the prevalence of
hyperhomocysteinemia by almost one-half (Jacques, Selhub, Bostom, Wilson, &
Rosenberg, 1999). Despite folic acid fortification, hyperhomocysteinemia (defined as >13
µmol/L) is still found in approximately 9% of the U.S. population, likely due to poor B12
status, and remains a key risk factor for adverse health outcome.

c. Vitamin B12 and Cognitive Function
Despite the association of low vitamin B12 status with hyperhomocysteinemia, and
the later with cognitive decline, few studies have demonstrated an independent
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association between vitamin B12 and impaired cognition. In an early study, researchers
investigated the neuropsychiatry of megaloblastic anemia to distinguish which symptoms
were associated with vitamin B12 deficiency versus folate deficiency (Shorvon, Carney,
Chanarin, & Reynolds, 1980). Prior to this, no comprehensive study had been performed
on the neuropsychiatry of vitamin B12 deficiency since the early 1950s. Shorvon et al.
compared the neurological and psychiatric states of 84 patients admitted to a local
London hospital. Inclusion criteria included megaloblastic anemia associated with a
serum vitamin B12 of less than 150 ng/L (110.7 pmol/L) or a serum folate below 2.5 µg/L
(5.7 nmol/L) together with an RBC folate level below 150 µg/L. Patients with evidence
of both deficiencies, and/or diseases known to impact the metabolism of these nutrients
were excluded from the study. Seventy-seven of the 84 patients underwent an
electrophysiological study to identify peripheral nerve function (Shorvon et al., 1980).
Fifty patients (59%) were diagnosed with vitamin B12 deficiency and 34 (41%)
had confirmed folate deficiency. The ratio of males to females in each group was similar,
although the mean age was higher in the vitamin B12 deficient group (mean age: 60 years)
compared to the folate deficient group (mean age: 40 years). Of the 50 patients with
vitamin B12 deficiency, 32 had pernicious anemia. Hematological data showed no
significant differences between the two groups with respect to hemoglobin and mean cell
volume (MCV). Approximately two-thirds of both groups had some form of
neuropsychiatric abnormality. Among the vitamin B12 deficient group, 20 patients (40%)
had peripheral neuropathy compared to only 6 patients (18%) of the folate deficient
group. In addition, eight patients with vitamin B12 deficiency had subacute combined
cord degeneration. This condition affects the spinal column, brain and peripheral nerves
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first, by damage to the myelin sheath, and later, damage to the nerve cell itself.
Symptoms can include paresthesia, unsteady gait, depression, visual changes, and
changes in mental status, including cognitive decline and dementia. There were no cases
of subacute combined cord degeneration in the folate deficient group.
Further findings showed 28 patients (65%) with vitamin B12 deficiency
demonstrated peripheral nerve disease based on electrical evidence, while only 6 patients
(21%) with folate deficiency reported the abnormal outcomes. The authors reported that
the clinical and electrical evidence suggests that neuropathy is approximately three times
more common in vitamin B12 deficiency than in folate deficiency. While this study was
not designed to detect changes in cognitive decline, it alludes to the potential, particularly
with subacute combined cord degeneration observed only in the patients with vitamin B12
deficiency (Shorvon et al., 1980).
In a randomized placebo-controlled study, researchers investigated the effects of
B-vitamin supplementation on Alzheimer’s disease (AD) related gray matter atrophy over
a two-year period in 156 elderly participants (Douaud et al., 2013). Eighty subjects (mean
age 77 years) received the B-vitamin mixture (0.8 mg/d of folic acid, 0.5 mg/d of vitamin
B12, 20 mg/d of vitamin B6) and 76 subjects (mean age 76 years) received a placebo.
There were no significant differences in demographics, cognitive function, or biomarkers
measured at baseline between the two groups.
Local gray matter volume was assessed at baseline and again after 2 years via
MRI scan. Atrophy was found in similar areas in both groups; however, the group
receiving the B-vitamins showed a significant reduction of atrophy in the posterior
regions of the brain, those most affected by AD (Douaud et al., 2013).
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The average reduction of gray matter
over the two-year period was 3.7%
(±3.7) in the placebo group and 0.5%
(±2.9) in the B-vitamin group. Figure
1 shows the loss of gray matter
volume (shown in yellow) for both
groups. The amount of yellow
corresponds to the volume of loss.

Fig 1: Regional loss of gray matter volume. Douaud et al., 2013

To investigate the effect of serum Hcy on gray matter decline with and without
treatment, the researchers dichotomized each group by serum Hcy level (those above and
those below the median of 11.06 µmol/L). Within the placebo group, participants with
higher serum Hcy had more gray matter atrophy compared to those with lower Hcy
concentrations. In the treatment group, the researchers found no difference in atrophy
between the two Hcy groups. When testing the effect of B-vitamin supplementation on
overall atrophy, the authors found no effect of the treatment in participants with low
baseline serum Hcy levels. In the higher serum Hcy group however, B-vitamin
supplementation had a protective effect on gray matter loss. Those with high serum Hcy
showed reduced gray matter atrophy after two years of B-vitamin treatment. The average
loss of gray matter over a two-year period for those with high serum Hcy in the placebo
group (n=35) was 5.2% (± 3.4) compared to those with high serum Hcy in the B-vitamin
group (n=42) who showed an average loss of 0.6% (± 2.1) (Douaud et al., 2013).
The researchers state that the reduced atrophy in regions of the brain susceptible
to AD appeared to be mediated by lowering of serum Hcy levels. Furthermore, while the
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B-vitamin treatment led to a change in plasma vitamin B12 and plasma folate
concentrations, it was only plasma vitamin B12 that appeared to play a role in modifying
Hcy levels. The lack of influence of serum folate may be due to the fact these participants
had good folate status (mean folate 29 nmol/L) at baseline. No participant was found to
be vitamin B12-deficient (based on the cutoff level of <150 ng/L). Nonetheless, changes
in gray matter atrophy were significantly associated with a change in plasma vitamin B12
levels. Elevated serum Hcy is an inhibitor of both methylation reactions and the
proliferation of neuronal cell precursors. Vitamin B12 is responsible for methylation in the
brain, and its deficiency can disrupt neuronal cell proliferation. Thus, it is plausible that
vitamin B12 is essential in maintaining adult neurogenesis in the regions of the brain
affected by AD (Douaud et al., 2013).

d. Vitamin B12 and Type 2 Diabetes
Neuropathic manifestations from microvascular complications are highly
associated with diabetes. Vitamin B12 deficiency can exacerbate existing neuropathic
conditions in people with type 2 diabetes (T2DM) (Adaikalakoteswari et al., 2014).
Metformin, a class of insulin sensitizing drugs called biguanides, is the most commonly
prescribed oral hypoglycemic agent in patients with T2DM (Liu et al., 2009). Use of
metformin is well known to impede the absorption of vitamin B12 resulting in a
deficiency; however, it is often overlooked and seldom investigated. Researchers sought
to define the prevalence of vitamin B12 deficiency in a T2DM population within a
military primary care practice (Pflipsen et al., 2009). Men and women (n=195) 45 years
of age and older, with a diagnosis of T2DM were included in the study. Vitamin B12
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deficiency was defined as a plasma B12 level <100 pg/mL (<74 pmol/L), or a plasma B12
level of 100-350 pg/mL (74 – 258 pmol/L) with a corresponding methylmalonic acid
(MMA) level >243 nmol/L and/or a homocysteine (Hcy) level >11.9 nmol/L. Inclusion
of alternative biomarkers of B12 status have been shown to improve the sensitivity and
specificity of detecting a deficiency and may help to identify early, asymptomatic cases
of B12 deficiency before irreversible neurological damage. Only 60% of those with
vitamin B12 deficiency have clinical manifestations of macrocytic anemia; thus,
additional diagnostic measures are essential (Stabler, 2013).
Serum vitamin B12 levels ranged from 91 to 2818 pg/mL (67 to 2079 pmol/L).
Only one subject was deficient based solely on serum B12 <100 pg/mL, while 79 had
insufficient levels of serum vitamin B12 of 100-350 pg/mL (74 – 258 pmol/L), 43
proceeded to have either elevated MMA (>244 nmol/L) and/or elevated serum Hcy levels
(>11.9 nmol/L) indicating vitamin B12 deficiency. In total 44 participants (22%) with
T2DM were B12 deficient. Patients with B12 deficiency had T2DM significantly longer
than those who were B12 sufficient (Pflipsen et al., 2009). When a subsequent analysis
was conducted defining all participants with serum B12 levels <350 pg/mL (<258
pmol/L), patients using metformin were at significantly greater risk of B12 deficiency.
While patients taking metformin had a significantly lower B12 status compared to patients
not taking the medication (425.99 pg/mL and 527.49 pg/mL, respectively), metformin
use was not significantly associated with B12 deficiency. The authors stated that their
inclusion of diagnostic criteria other than serum B12 levels (MMA and Hcy) in defining
B12 deficiency likely improved the diagnosis of the condition. However, at the time there
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were no published studies examining the prevalence of B12 deficiency utilizing the more
sensitive and specific diagnostic markers in the general population.
While this study was innovative, it contained some limitations. The cohort was
from a military family medicine center that was deemed to be exceptional in the chronic
care of diabetes. Thus, most participants were considered to have well-controlled T2DM,
which may not be generalizable to the rest of the population. In addition, this study did
not investigate the clinical manifestations of B12 deficiency such as megaloblastic
anemia. Analyses of mean corpuscular volume (MCV), red cell distribution width
(RDW) and/or hemoglobin and hematocrit (H/H) may have been advantageous in further
defining clinical outcomes. Furthermore, the cross-sectional design does not allow for
causality; however, the aim of the study was to define vitamin B12 deficiency in a diabetic
population, for which the design was appropriate.
Data from the 1999-2006 National Health and Nutrition Examination Survey
(NHANES) were published on the association of vitamin B12 deficiency in US adults ≥50
years with (n=1,621) and without (n=6,867) T2DM and with and without metformin
usage (Reinstatler, Qi, Williamson, Garn, & Oakley, 2012). The authors defined
biochemical vitamin B12 deficiency as serum levels ≤148 pmol/L, borderline deficiency
as >148 to ≤221 pmol/L, and normal as >221 pmol/L. Exclusion criteria included
pregnancy, HIV+ status, B12 injection therapy, prediabetes, and elevated creatinine levels,
but included participants with existing liver and/or renal conditions. The authors
examined B12 supplement use, acid blockers, homocysteine levels, MCV, hemoglobin
A1c %, and serum folate among participants with and without T2DM. The variables were
then stratified by metformin use (yes, n=575; no, n=1,046) within the T2DM group. Of
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interest, serum vitamin B12 was significantly lower in participants with T2DM taking
metformin compared to those with T2DM not taking the medication (p=0.0116), as well
as to non-diabetics (p=0.011). The weighted prevalence of vitamin B12 deficiency
adjusted for age, race, and gender was 5.8% for those with T2DM taking metformin, and
2.2% not taking metformin, and 3.3% in those without T2DM. The investigators applied
the Fleiss formula for attributable risk in cross-sectional data and found that among all
cases of vitamin B12 deficiency, 3.5% were attributable to metformin use. Among those
with T2DM, 41% of the vitamin B12 deficient cases were attributable to the medication
usage. Although serum homocysteine levels were investigated, no significant differences
were found (Reinstatler et al., 2012).
Interestingly, the researchers noted that despite the observed effects of metformin
use on vitamin B12 status, the overall deficiency percentage may not indicate a public
health concern. The authors also intentionally did not include MMA as an indicator of
vitamin B12 status. They concluded that the use of MMA and other functional measures
of vitamin B12 status remains controversial. However, findings from a roundtable
discussion on measurement of vitamin B12 status biomarkers in NHANES data revealed
that measuring a circulating biomarker such as serum vitamin B12 or holoTC and a
functional biomarker such as MMA or Hcy is preferable to measuring only one
biomarker in NHANES (Yetley et al., 2011). In addition, the panel concluded that if
NHANES reinstates measurement of vitamin B12 status in the future, the biomarkers will
be serum vitamin B12 and plasma MMA.
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5. Folate, Vitamin B12 and Telomere Length
As two important factors in one-carbon metabolism, vitamin B12 and folate status
vary in their association with telomere length. In most reports, vitamin B12 has shown to
have no association with telomere length, while studies investigating a relationship
between folate levels and telomere length appear to be more complex. One study looked
at the association between folate status and the 677C>T polymorphism of the MTHFR
gene and telomere length (Paul et al., 2009). The authors controlled for vitamin B12 in
their analyses, but also reported that plasma vitamin B12 concentration was not associated
with telomere length in their population of 195 healthy men. Interestingly, the authors
reported a U-shaped relationship between plasma folate status and telomere length, with
longer telomeres associated with both low and high folate status. The investigators
reported that as plasma folate concentration moved toward the median (11.6 nmol/L),
there was a trend toward a corresponding decrease in mean telomere length. In those with
folate concentrations below the median, there was a corresponding increase in telomere
length. Thus, the relative telomere length of men in the lowest quartile of plasma folate
concentration tended to be higher than the telomere length of men in the highest quartile
of plasma folate concentration (p = 0.11). The authors suggested that longer relative
telomere length observed among those with very low folate status may be a result of
telomeric dysregulation due to hypomethylation of DNA (Paul et al., 2009).
This finding was supported by a study utilizing an in vitro model of chronic folate
deficiency (Bull et al., 2014). Cells were grown under three simulated conditions:
deficient, replete, and/or supraphysiological. The folate-deficient cells had a significantly
longer mean telomere length at day 7 and 14 compared to the other two cell conditions at
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the same time points (p=0.02). However, the mean telomere length dropped sharply after
day 14 to below that of the other two cell conditions by day 42, indicating an increase in
telomere length with the beginning of folate deficiency (days 7–14), followed by a
shortening of telomere length with chronic deficiency (days >14).
In a previous study, the authors investigated the relationship of plasma folate,
homocysteine, vitamin B12 and RBC folate to telomere length in a fairly homogeneous
population of 90 predominantly Caucasian, healthy men and women (Bull, O’Callaghan,
Mayrhofer, & Fenech, 2009). In a dichotomous grouping of younger (18-32 years) and
older (65-83 years) participants, the authors reported the mean plasma folate and RBC
folate concentrations were significantly higher in the older subjects compared to the
younger cohort (p = 0.0001 for both); however, no correlations were observed between
plasma and/or RBC folate and telomere length, nor with plasma vitamin B12 and telomere
length in this study. In addition, no differences were observed in the plasma vitamin B12
concentrations between the two cohorts. Of note, this study was limited in sample size
and likely lacked sufficient power to detect a significant finding if indeed one existed
(Bull et al., 2009).
Despite the above findings, current research suggests vitamin B12 deficiency is
more common in older adults. Vitamin B12 deficiency ranges from 5–40% (depending on
the definition used) resulting from inadequate vitamin B12 intake and more commonly,
impaired absorption (Wong, 2015). According to NHANES data, the prevalence of
vitamin B12 deficiency (serum B12 <148 pmol/L) among those 20–39 years of age was
<3%, and close to 4% for those aged 40–69 years (Allen, 2008). For individuals over 70
years, the prevalence was double that of the younger group at 6%. Among those
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considered to be marginally deficient (serum B12 of 148–221 pmol/L), the percentage
increased to 14%–16% in those aged 20–59, to over 20% in those over 60 years old. In
other parts of the world, prevalence of deficient or marginal vitamin B12 status among
children and adults can range from 40% in Latin America to as high as 70% - 80% in
Africa and India, respectively (Allen, 2008).
In a seminal publication by Liu et al. investigating factors of one-carbon
metabolism from the Nurses’ Health Study (NHS), the authors reported no associations
between plasma folate (P-trend = 0.90), plasma vitamin B12 (P-trend = 0.94), plasma vitamin
B6 (PLP) (P-trend = 0.78), and plasma homocysteine levels (P-trend = 0.57) and relative
telomere length in a total of 1,624 participants, after adjusting for age, smoking, body
mass index (BMI), and physical activity (Liu et al., 2013). Higher plasma cysteine levels
were significantly associated with shorter relative telomere length in this population (Ptrend

= 0.02). Furthermore, the authors reported no significant associations found among

the dietary intakes of folate (P-trend = 0.94), vitamin B12 (P-trend = 0.55), and vitamin B6 (Ptrend

= 0.71) and quartiles of relative telomere length after adjusting for the potential

confounders (J. J. Liu et al., 2013).
The authors noted that this was the only study investigating all factors of onecarbon metabolism on telomere length. While this study demonstrated strength in sample
size and use of physiological biomarkers of vitamin B12 and folate, it has some
limitations. The study was cross-sectional by design, which negates the ability to make
causal inference. In addition, the study was conducted predominately in white women. It
remains possible an association exists in men or in different racial/ethnic groups. Finally,
the only representation of vitamin B12 and folate status were plasma levels of the

49

vitamins. The authors did not investigate MMA as a biomarker of vitamin B12 status
which has been reported in literature to be superior to plasma vitamin B12 levels in
defining total body status. Additionally, the authors did not investigate RBC folate, which
has been suggested to be a better representation of current folate status.
Data from the Framingham Offspring Cohort (1991-1995 and 1995-1998) yielded
an association between plasma folate levels post-folic acid fortification and telomere
length (Paul et al., 2014). The authors controlled for covariates including age, sex, BMI,
smoking, alcohol intake, serum creatinine, and menopause status in 1,044 men and
women. General linear regression models were used to determine the association between
telomere length and plasma folate in quintiles, as well as for folic acid fortification and
supplement use. The mean telomere length of those participants examined before folic
acid fortification was 6.95 kb (±0.04), while individuals examined post-fortification had a
mean telomere length of 6.88 kb (±0.04) (p = 0.14) (Paul et al., 2014). When plasma
folate concentrations were divided into quantiles, those in the fifth quintile (highest 20%
of serum folate levels) had a significantly shorter mean telomere (-180 bp) length
compared to those in the second quintile (p < 0.01) (Paul et al., 2014). While not
significant, individuals in the first quintile of plasma folate had a shorter mean telomere
length compared to those in the second quintile, revealing a non-linear, bell-shaped
relationship. These data coincide with previous literature supporting the relationship
between folate and markers of health status. Low plasma folate is associated with DNA
hypomethylation and telomere length is determined by DNA integrity. Loss of DNA and
histone methylation, for which folate plays a major role, results in a dysregulation,
yielding unusually long, dysfunctional telomeres in cell culture (Bull et al., 2014). Thus,
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low, as well as elevated plasma folate, can impair DNA synthesis and adversely affect
telomere length. Extreme plasma folate concentrations have been associated with poorer
health outcomes, and in this study, a shorter mean telomere length (Ericson et al., 2010;
Paul et al., 2009).
Data were collected both pre- and post-folate fortification. While the mean
telomere length of participants was shorter post-fortification, the difference was not
significant (Paul et al., 2014). The investigators also looked at supplement usage.
Multivitamin (MVI) users had a significantly shorter telomere length compared to nonusers (p = 0.015). This finding contrasts with that of Xu et al., who found a positive
correlation between MVI use and telomere length (Xu et al., 2009). Interestingly, 83% of
those in the fifth quintile of plasma folate (shortest telomere length) were multivitamin
users. Increasing plasma folate concentration was associated with a shorter mean
telomere length (second through fifth quintiles) even after multivitamin users were
removed from the analysis (Ptrend<0.01). Additionally, while plasma folate concentration
was negatively associated with plasma homocysteine levels (r= -0.2426, p< 0.0001), the
investigators found no association between serum vitamin B12 and/or serum pyridoxal
5’phosphate (PLP) and telomere length (Paul et al., 2014).
Although the study by Xu et al. (2009) found an association between elevated
plasma folate and shorter telomere length, other studies have found a positive relationship
between the two variables. In a population-based cohort, investigators measured
homocysteine and serum folate levels in 1,319 healthy subjects (91.5% women)
(Richards et al., 2008). The authors reported higher serum folate levels were associated
with an increase in age-adjusted telomere length (β = 0.01, 95% CI: 0.004-0.017)
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(Richards et al., 2008). Homocysteine levels were found to be inversely correlated with
telomere length after adjusting for age, C-reactive protein (CRP) levels, physical activity,
and glomerular filtration rate (GFR) (Ptrend=0.007). When serum folate was dichotomized
(high and low) within tertiles of homocysteine concentration, the difference in telomere
length between the high folate group within the lowest tertile of homocysteine and the
low folate group within the highest tertile of homocysteine was 159 bp (95% CI: 64 -255;
p = 0.001). According to the researchers, this is equivalent to 8.6 years of biological
aging. Within each tertile of homocysteine, individuals with higher serum folate levels
had a longer mean telomere length (Ptrend =0.002).
Similarly, researchers found that higher plasma folate status in older men was
associated with longer telomere length (p = 0.04) (Bull et al., 2009). However, this
association was not observed in older women, or in the younger cohort. The authors also
reported a significant association between higher homocysteine levels and shorter
telomere length in older men (p = 0.004). Likewise, Rane et al. found a significant
association between elevated Hcy levels and shorter telomere length in their study of 100
adult men and women randomly selected from a prospective population-based cohort of
63,257 Chinese citizens (Ptrend = 0.014) (Rane et al., 2015). While mean telomere length
was longest among those in the highest tertile for folate concentration, the association did
not reach statistical significance.
D. Summary
As one of the common hallmarks of aging, telomere attrition is associated with
morbidity and mortality. Use of telomere length as a biomarker of health and aging is
gaining credence in epidemiological studies. Shorter telomeres have been associated with
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many chronic health outcomes such as cardiovascular disease, Alzheimer’s disease,
cancer, and diabetes. Furthermore, telomere length has also been shown to be an
independent risk factor and predictor for insulin resistance, type 2 diabetes, as well as
cardiovascular disease related events including myocardial infarction and stroke.
Micronutrients are vital components for proper body functioning; however, in
excess, these essential compounds can be detrimental toward optimal health. To date,
evidence of a causal relationship between poor iron status and/or factors of one-carbon
metabolism and telomere length remains elusive. Of the studies performed, many have
been potentially underpowered, or lacked sufficient biomarkers for proper categorization
of exposure variables.
The relationship between folate and telomere length thus remains controversial,
with evidence of both non-linear, linear, and no associations found (Bull et al., 2009; Paul
et al., 2009, 2014; Richards et al., 2008). It remains unclear as to whether there is an ideal
folate status at which telomere length is optimal. Furthermore, while no studies have
demonstrated a direct association with vitamin B12 status and telomere length, to our
knowledge, they have not used MMA as an additional biomarker of vitamin B12 status.
Evidence suggests vitamin B12 and folate play key roles in factors that may influence
telomere length; thus, further investigation on factors of one-carbon metabolism would
fill a much-needed gap in the literature.
To our knowledge, no studies have published data on iron deficiency and
telomere length; thus, it is unclear whether low iron status or iron deficiency is associated
with telomere length. As a public health concern, iron deficiency is the most common
nutritional deficiency worldwide and leading cause of anemia in the United States (World
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Health Organization, 2001). Although two studies have alluded to the negative effect of
high iron status (hemochromatosis) on telomere length (Mainous III et al., 2013, 2014),
larger studies in diverse populations are lacking. Hence, research on overall iron status
and telomere length is warranted.

E. Objective
The objective of this research project is to investigate the impact of micronutrient
status on telomere length. Our central hypothesis is that altered micronutrient status (i.e.
low vitamin B12 status, suboptimal and/or elevated folate status, suboptimal and/or
elevated iron status) will be associated with a shorter mean telomere length when
compared to those with sufficient status of the corresponding micronutrients. There is
plausible evidence to suggest the use of telomere length as a biomarker for predicting
disease risk and mortality. Our rationale for undertaking this research is that by
identifying modifiable nutritional risks associated with shorter telomere length, we may
be able to positively impact biological aging and disease risk by correcting the impaired
micronutrient status of vulnerable individuals.
1. Papers #1 and #2: Impaired Levels of Select Factors of One-Carbon Metabolism
are Associated with a Shorter Mean Telomere Length in Adult Men and Women.
Our working hypothesis for this aim is that suboptimal vitamin B12 and folate status are
associated with a shorter mean telomere length in adult men and women, independent of
one another. Our experimental approach will be to investigate the association between
vitamin B12 and folate status, determined by serum vitamin B12 concentration and
methylmalonic acid (MMA) level for B12 status and serum folate concentration for folate
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status, and mean telomere length in base pairs to determine the extent to which
suboptimal vitamin B12 status and/or suboptimal or elevated folate status are
independently associated with telomere length, in a nationally representative sample of
adult men and women in the United States.
a. Specific Aim: Factors of One-Carbon Metabolism Status and Telomere Length
To evaluate the association of vitamin B12 and folate status on telomere length in
a nationally representative sample of adult men and women.
Hypothesis 1a: Compared to participants with adequate vitamin B12 status, men and
women with suboptimal vitamin B12 status will have a shorter mean telomere length after
controlling for relevant covariates including folate status.
Hypothesis 1b: Compared to participants with adequate folate status, men and women
with deficient, as well as elevated plasma folate, will have a shorter mean telomere length
after controlling for relevant covariates including B12 status.
Hypothesis 1c: Compared to subjects with sufficient vitamin B12 and folate status, men
and women with suboptimal vitamin B12 status and elevated folate status will have a
shorter mean telomere length after controlling for relevant covariates.
Gap in Knowledge: Previous studies investigating micronutrient status have reported
inconclusive results. Studies investigating vitamin B12 have found no association between
serum B12 or low vitamin B12 intake and telomere length. One study did find an
association with use of vitamin B12 supplements and a longer mean telomere length.
To our knowledge, no study has explored the association of suboptimal vitamin
B12 status (defined by serum vitamin B12 and MMA concentrations) and telomere length
in a nationally representative, population-based sample. In addition, investigations of

55

folate status and telomere length have yielded varying results, and the association appears
to be complex. Research has demonstrated a non-linear, bell-shaped relationship between
plasma folate and mean telomere length, as well as a linear relationship between the two
variables. Given the interwoven relationship between folate and vitamin B12 with regards
to metabolism and nutrient status, the two micronutrients should be investigated
concurrently.
4. Paper #2: Impaired Iron Status is Associated with Shorter
Telomere Length in Adult Men and Women.
Our working hypothesis for this aim is that low iron status (iron-deficiency anemia and
iron deficiency) as well as elevated iron status, are associated with a shorter mean
telomere length in adult men and women. Our experimental approach will be to
investigate the association between iron status, determined by serum iron concentration,
serum ferritin, transferrin saturation percent, erythrocyte protoporphyrin level, and
hemoglobin concentration, and mean telomere length to determine the extent to which
suboptimal iron status is associated with telomere length in a nationally representative
sample of adult men and women.
a. Specific Aim: Iron Status and Telomere Length
To evaluate the association of iron status on telomere length in a nationally
representative sample of adult men and women.
Hypothesis 2a: Compared to subjects with adequate iron status, men and women with low
iron status will have a shorter mean telomere length after controlling for relevant
covariates.
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Hypothesis 2b: Compared to subjects with adequate iron status, men and women with an
elevated iron status will have a shorter mean telomere length after controlling for relevant
covariates.
Gap in Knowledge: To our knowledge, no study has investigated the impact of iron
deficiency on telomere length in adult men and women. Few studies have examined the
role of elevated iron status on telomere length in adults. Of the studies conducted,
research has focused on transferrin saturation and genetic markers of hemochromatosis as
indicators of iron status. Furthermore, the use of multiple biomarkers of iron status
including serum iron, ferritin levels, transferrin saturation percentage (TS%), erythrocyte
protoporphyrin, and hemoglobin levels, will provide additional criteria for determining
iron deficiency as well as that of elevated iron status or iron overload.
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CHAPTER 2
FACTORS OF ONE-CARBON METABOLISM AND
TELOMERE LENGTH IN ADULT MEN AND WOMEN
A. Introduction
Telomeres are repetitive, non-coding nucleotide sequences at the end of all
vertebrate chromosomes (TTAGGG in humans) first recognized by Muller and
McClintock in 1938 and 1941, respectively through their work with Drosophila
(McClintock, 1941). Telomeres function as protective caps on the chromosomes and play
an indispensable role in DNA replication and stability. Credit for this discovery went to
Blackburn, Greider, and Szostak, who were awarded the Nobel Prize in Physiology or
Medicine in 2009. The guanine-rich 3’ projection of the telomere is thought to be of
particular importance; acting as a buffer to protect gene coding sequences enabling gene
continuity through DNA replication (Greider, 1998). However, the guanine residues of
telomeres also make them highly susceptibility to damage caused by oxidative stress
(Houben, Moonen, van Schooten, & Hageman, 2008; Matthews et al., 2006; Von
Zglinicki, 2002).
Telomere attrition has become a widely accepted cellular event associated with
aging. Additionally, telomeric loss and dysfunction have been associated with chronic
conditions such as cardiovascular disease (Fitzpatrick et al., 2007), hypertension (Samani
et al., 2001), type 2 diabetes, (Verhulst et al., 2016; Willeit et al., 2014; Zhao et al., 2014)
Alzheimer’s disease (Panossian et al., 2003), and certain cancers (Du et al., 2015; Willeit
et al., 2010) independent of chronological age. Thus, telomere length assessment holds
potential as a biomarker of risk assessment for adverse health outcomes.
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It is well known that dietary factors can influence the risk of chronic disease, but
the mechanisms of action by which micronutrient status influences chronic disease
outcomes are complex and, in most cases, uncertain. Antioxidants can quench reactive
oxygen species (ROS) resulting from oxidative stress, and thus may provide protection to
susceptible telomeres. Several studies have demonstrated a positive relationship between
dietary antioxidant intake and telomere length (Boccardi et al., 2013; García-Calzón,
Zalba, et al., 2015; Marcon et al., 2012; Mazidi, Kengne, & Banach, 2017), as well as
antioxidant supplementation (Xu et al., 2009). Factors affecting one-carbon metabolism
could also influence telomere length; however, findings from studies investigating intake
of nutrients involved in this pathway have been inconsistent (Liu et al., 2013).
Folate and vitamin B12 are two important B-vitamins involved in one-carbon
metabolism. Xu et al. (2009) reported a longer mean telomere length associated with
women who consumed vitamin B12 supplements compared to non-users, although
vitamin B12 status was not measured. In most studies, plasma vitamin B12 concentration
has not been associated with telomere length, and the association between plasma folate
and telomere length has been inconsistent (Bull et al., 2009; Liu et al., 2013; Paul et al.,
2014). In previous studies involving telomere length, B12 status had been identified using
serum vitamin B12 level as the sole indicator; while the association between plasma folate
concentration and telomere length has been reported to be a U-shaped relationship (Paul
et al., 2009), a bell-shaped relationship (Paul et al., 2014), as well as having no
association (Liu et al., 2013).
Of recent interest are reports of the apparent negative interactions between
elevated folate intakes in participants and low B12 status on various health outcomes
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(Morris et al., 2007; Morris, Selhub, & Jacques, 2012). Using the NHANES database,
researchers investigated the cross-sectional association between serum folate and vitamin
B12 status relative to macrocytic anemia and cognitive impairment among 1,459 elderly
participants. After controlling for potential confounders, low B12 status (<148 pmol/L
and/or MMA >210 nmol/L) was associated with increased risk of anemia (OR 2.7; 95%
CI 1.7, 4.2), macrocytic anemia (OR 1.8; 95% CI 1.01, 3.3), and cognitive impairment
(OR 2.5; 95% CI 1.6, 3.8) (Morris et al., 2007). Additionally, those with low B12 status
and elevated serum folate (>59 nmol/L) had a greater risk of anemia (OR 3.1; 95% CI
1.5, 6.6) and cognitive impairment (OR 2.6; 95% CI 1.1, 6.1) (Morris et al., 2007).
Explicitly, anemia and cognitive impairment were observed nearly five-times as often in
this group, compared to the group with normal status in both vitamins. In contrast,
normal vitamin B12 status (>256 pmol/L) coupled with high folate, provided protection
against cognitive impairment (OR 0.4; 95% CI 0.2, 0.9) (Morris et al., 2007).
In a longitudinal study, the same authors further investigated B12 and folate status
and cognition in 549 participants using the prospective Framingham Heart Study (FHS)
and the Mini-Mental State Examination with an 8-year follow up (Morris et al., 2012).
Vitamin B12 and folate status were assessed in quintiles. The average rate of cognitive
decline was 0.24 points/year. There was a significantly faster rate of cognitive decline
(0.35 points/year) reported among participants in the lowest two quintiles (< 256.8
pmol/L) compared to the upper three-fifths (≥ 256.8 pmol/L) of vitamin B12 status. With
folate, the lowest two quintiles and the upper most quintile had similar and faster rates of
cognitive decline, compared to the third and fourth quintiles. This parallels data on folate
status and telomere length in which the lowest and highest concentrations of folate have
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negative outcomes. Furthermore, in the presence of low B12 status, high plasma folate (≥
20.2 nmol/L) exacerbated the rate of cognitive decline to approximately 1-point per year
(Morris et al., 2012). To date, no study has investigated the possible interaction of
vitamin B12 and folate status on telomere length.
B. Material and Methods
1. Study Population
Data from the National Health and Nutrition Examination Survey (NHANES)
cycles 1999-2000 and 2001-2002 were used in our analyses because telomere length has
only been measured in these two cycles. The NHANES is conducted by the National
Center for Health Statistics (NCHS), which is part of the Centers for Disease Control and
Prevention (CDC) and is responsible for publishing health statistics on a nationally
representative sample of the US population. The NHANES survey data include
information on demographic, socioeconomic, dietary, and health-related questions, as
well as a laboratory and physical examination component. Participants are selected using
a multistage cluster sampling design with oversampling occurring for persons aged 60
and older, African Americans, and Hispanics.
Eligible participants included men and women aged 20 years and older, who had
blood stored for DNA analysis and subsequent mean T/S ratio data available. Of the
original 7,827 participants with data on telomere length, 33 participants were excluded
for missing data on the primary exposure variables (serum vitamin B12 and
methylmalonic acid (MMA), a biomarker of vitamin B12 status). Serum vitamin B12 and
folate concentrations may appear artificially depressed or elevated in patients with
chronic liver or kidney disease. Renal failure is a common reason for elevated serum B12
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levels (Patil, Bhosle, & Malik, 2016). Thus, we further excluded men and women with
elevated serum creatinine (1.7 mg/dL (n = 81) and 1.5 mg/dl (n = 40), respectively), and
those who answered yes to questions KIQ020 [KIQ022] (ever told you had weak/failing
kidneys?) (n = 211), MCQ170L (do you still have a liver condition?) (n = 92), as well as
those with elevated liver enzymes (ALT ≥125 U/L, AST ≥80 U/L, and Alkaline
Phosphatase ≥169 U/L; three standard deviations above the mean) (n = 66). Women who
had a positive pregnancy test (code URXPREG) were also excluded from the study (n =
443), bringing the total loss of participants to 966. After reviewing the data for outliers
and/or possible erroneous values via scatterplot data, participants with a telomere length
greater than 10,000 base pairs (bp) (n=3), a serum vitamin B12 level above 10,000 pmol/L
(n=11), and/or a serum folate level 3 SD above the mean (≥ 93.3 nmol/L) (n = 108) were
excluded from the sample population. The final sample size consisted of 6,739 men and
women for whom data on telomere length, vitamin B12 status, and folate status were
available. The inclusion of all covariates (described below) in the adjusted multiple
regression models brought the total number of participants for all analyses to 5,941.
2. Variables
Telomere length was our primary outcome. With each NHANES data collection
cycle, blood samples are obtained and analyzed immediately. A small portion of the
blood was reserved for future analysis of DNA, including telomere length. The telomere
length assay was performed by Dr. Elizabeth Blackburn at the University of California,
San Francisco (Cawthon, 2002). Polymerase chain reaction (PCR) methodology was used
to measure the telomere length (T) relative to a standard reference DNA (S) producing a
T/S ratio. Samples had been assayed in duplicate, three times on three different days,
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resulting in 6 data points that were then averaged. The final interassay coefficient of
variation was 6.5%. The formula reported in the NHANES database for converting T/S
ratio to a more intuitive base pair variable is (3,274 + 2,413 * (T/S)). This formula is
calculated based on the comparison of telomeric restriction fragment (TRF) length from
Southern Blot analysis and T/S ratios using DNA samples from the human diploid
fibroblast cell line IMR90 (Cawthon, 2002; Needham et al., 2013).
The main exposure variables were vitamin B12 status, determined using both
serum vitamin B12 and methylmalonic acid (MMA) levels, and folate status. Vitamin B12
and folate concentration measurements were performed using Quantaphase II
Folate/vitamin B12 radioassay kit from Bio-Rad Laboratories. Analysis of MMA
concentration was performed by gas chromatography and a mass selective detector using
ion monitoring.
Based on a previous study examining vitamin B12 status and macrocytic anemia
(Morris et al., 2007), low vitamin B12 status was defined as a serum vitamin B12 level of
≤148 pmol/L and/or a serum MMA level of ≥210 nmol/L. This value is based on the
upper end of the reference range for serum vitamin B12-replete participants with normal
creatinine levels. Folate status was categorized as suboptimal, sufficient, and elevated.
Serum folate levels were based on guidelines set forth by the World Health Organization
on serum and red blood cell folate concentrations for assessing folate status in
populations; the suboptimal serum folate cut-off value was set at ≤13.4 nmol/L, and
elevated serum folate at ≥ 45.3 nmol/L (World Health Organization, 2015). We defined
sufficient folate status as those concentrations falling in between suboptimal and
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elevated; thus, participants with serum folate levels greater than 13.4 nmol/L and less
than 45.3 nmol/L were considered sufficient.
The demographic covariates for this study included age, sex and race/ethnicity.
Age was a continuous variable in years, sex was coded “male” or “female,” and
race/ethnicity was coded “White/non-Hispanic,” “Mexican/Hispanic,” “Black/nonHispanic,” and “Other/Multi-Racial.”
Markers of socioeconomic status included educational status and annual
household income. Educational status consisted of “≤11th grade,” “high school graduate
or GED equivalent,” and “some college or beyond.” Annual household income was
determined to be non-significant in the model and was later dropped from further
analyses.
Smoking status was categorized as “never,” “former,” and “current” smokers.
Current smokers were further categorized by average number of cigarettes smoked per
day. The “never” group consisted of those participants who answered no to question
SMQ020 (smoked at least 100 cigarettes in life?). Former smokers were those who
answered yes to SMQ020, but no to SMQ040 (do you now smoke cigarettes?). Current
smokers were those who answered 1 or 2 (every day or some days, respectively) to
question SMQ040 (Do you now smoke cigarettes?). This group was further categorized
using the answer to question SMD070 (# cigarettes smoked/day now?), into <10
cigarettes/day, 10 to 19 cigarettes/day, and ≥20 cigarettes/day. The smoking variable was
based on cigarette smoking only. Other methods of smoking or use of chewing tobacco
were not assessed.
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Alcohol intake was categorized as “never,” “former moderate,” “former heavy,”
“current moderate,” and “current heavy.” There were 378 missing answers from
respondents, six of whom answered “unknown” for intake on the questionnaire. Never
drinkers were those answering no to having had at least 12 alcoholic drinks over the past
12 months and no to having had at least 12 alcoholic drinks in a lifetime. Former drinkers
were those who answered yes to at least 12 drinks in a lifetime, but no to having drank
alcohol over the past 12 months. Former drinkers were divided into moderate and heavy
intakes. Heavy drinkers answered yes to ever having ≥ five drinks every day. Current
drinkers were also divided into moderate and heavy alcohol intake. Current moderate
drinkers consumed an average of ≤ two drinks/day, while current heavy drinkers
consumed ≥ three drinks/day.
Blood glucose status was defined as normal, borderline, and diabetes using an
algorithm of biochemical markers including percent hemoglobin A1c (%A1c), fasting and
non-fasting plasma glucose levels, as well as medical history questionnaire data.
Participants were categorized as having diabetes if they answered yes to taking insulin, to
having been told they have diabetes by a doctor, and/or to taking oral glucose agents.
Biochemical data for diabetes included a %A1c of ≥6.5, a fasting plasma glucose of ≥126
mg/dL, a plasma glucose of ≥ 200 mg/dL, and/or a fasting glucose of ≥126 mg/dL with
an %A1c ≥5.7, but <6.5. Participants were categorized as borderline blood glucose status
if they answered yes to having been told they have pre-diabetes. Biochemical data for
borderline diabetes included a %A1c ≥5.7 but <6.5% with a fasting plasma glucose ≥100
mg/dL, but <126 mg/dL. The remaining participants were categorized as having normal
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blood glucose status if they did not meet the above criteria for impaired glucose. Those
lacking data on two or more of these markers were categorized as missing.
3. Statistical Analysis
Data analyses were performed using STATA/IC version 13.1 to test our
hypothesis that low vitamin B12 status, as well as suboptimal and/or elevated folate status
is associated with shorter telomere length in adult men and women. The continuous
variables included age, body mass index (BMI), serum vitamin B12 concentration, serum
folate, methylmalonic acid level (MMA), C-reactive protein (CRP), and homocysteine
levels, were reported as the unadjusted mean (±SD) by both vitamin B12 and folate status.
Categorical variables included sex, race, educational status, smoking status, alcohol
intake status, and blood glucose status, and were reported as counts (%) by vitamin B12
and folate status. The age-adjusted mean telomere length was calculated for the
categorical variables by exposure status. Statistical analyses for vitamin B12 status
subgroups (low and sufficient) were performed using a two-sample T-test analyses. We
used analysis of variance (ANOVA) and Chi-Squared test to examine whether covariate
distributions differed across folate status subgroups (suboptimal, sufficient, and elevated).
A p-value of < 0.05 was considered statistically significant for all tests. The main
outcome and exposures had equal variances based on results of Levenes’s test for
homoscedasticity. ANOVA analysis was used to calculate the age-adjusted mean
telomere length for vitamin B12 and folate status subgroups, and to test for effect within
our categorical covariates.
We tested our main hypotheses by evaluating vitamin B12 and folate status and
telomere length in a multiple linear regression model adjusting for potential cofounding
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variables. The above-mentioned covariates were assessed for their effect on telomere
length or confounding with vitamin B12 status and/or folate status. A multiple F-test was
used to test the statistical significance of the parameters in the model. If a variable
demonstrated no effect on the relationship between telomere length and our exposure
variables (p>0.05) the parameter was eliminated from the model. The normality of the
continuous variables was assessed via graphical methodology, C-reactive protein (CRP),
body mass index (BMI) and plasma homocysteine were subsequently log-transformed to
achieve greater homoscedasticity. We presented the telomere data as base pair units.
We fit linear regression models of vitamin B12 status and folate status, on the
outcome of telomere length adjusting for age alone, reported in model 1. Data are
presented as the change in mean telomere length (bp). We used the log-transformed mean
telomere (T/S) ratio in the linear regression analysis, prior to the calculation of bp, to
determine the β coefficient for age. We later used this value in determining an estimate of
biological aging associated with telomeric shortening. The regression coefficient for age
was -0.0058 (0.6%), which corresponded to telomere length reduction of 14.1 bp per each
one-year increase in participant age. Model 2 represents the multiple linear regression
that included sex and race, in addition to age. We chose to conduct the analyses in stages
due to the particularly strong correlation of age, as well as sex and race, with telomere
length. Model 3 is the fully-adjusted model that included the above-mentioned covariates,
as well as educational status, smoking status, alcohol intake status, BMI, blood glucose,
serum homocysteine and CRP levels.
Given the importance of adequate vitamin B12 status in folate metabolism, we
created an interaction term of vitamin B12 and folate status and formally tested it within
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the three multiple linear regression models described above. Multiple F-test analyses
were conducted to test for significance. We included age in the interaction term given the
significant correlation between it and our outcome. We then formally tested the
interaction term of B12 status, folate status, and age for significance.
We repeated the model including the interaction term of B12 and folate status with
stratification on age to determine if there was effect modification by age and followed
with multiple F-test analyses to test for significance. Analysis of variance (ANOVA) was
used in determining age-adjusted mean telomere length for the subgroups of the
interaction term and testing significance.

C. Results
1. Descriptive Data
Table 2.1 represents descriptive data for the 5,941 men and women in the study
population (49.2% female). The mean age was 50.1 years (±18.1). Non-Hispanic (NH)
white participants made up 51.9% of the population, 17.4% were NH-black, 28.2% were
Mexican/Hispanic, and 2.7% were multi-racial.
The mean telomere length for the total population was 5737.2 (7.4) base pairs
(bp), and for males and females it was 5706.2 (10.4) and 5769.1 (10.5), respectively. NHblack participants had the longest mean telomere length (5844.8 bp [17.8]) of any
racial/ethnic group, while Mexican/Hispanic participants had the shortest (5648.1 bp
[13.9]).
The total population age-adjusted mean (SE) for serum vitamin B12 and serum
folate concentrations were 387.3 (3.8) pmol/L, and 32.0 (0.2) nmol/L, respectively. There
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was an even distribution of B12 and folate status between men and women. NH-white
participants had the highest percentage of low B12 status (19.1%), while NH-black
participants had the lowest percentage (8.6%). A contrasting profile was found with
folate status distribution, where NH-black participants had a higher percentage of
suboptimal folate status (10.7%) compared to NH-white participants (5.3%). Elevated
folate status was highest among NH-whites (23.0%) and lowest among NH-blacks
(6.8%). Mexican/Hispanic participants fell between these percentages for both
suboptimal and elevated folate status (6.5% and 10.2%, respectively). Approximately
2.2% of our study population had a mean serum vitamin B12 level ≤ 148 pmol/L, and
15.5% had low vitamin B12 status. Approximately 6.6% of the study population was
classified as suboptimal folate status, and 16.4% were classified as elevated folate status.
Only 1.3% of the study population had low status in both nutrients, while 2.2% had low
vitamin B12 status coupled with elevated folate status. Table 2.2 represents the ageadjusted mean telomere length (SE) for the interaction between vitamin B12 and folate
status.

a. Vitamin B12 Status and Telomere Length
Table 2.3 presents data from multiple linear regression models of vitamin B12
status, folate status, and telomere length. In the age-adjusted model (Model 1), low
vitamin B12 status was significantly associated with shorter telomere length (β = -56.6 bp,
p=0.006). After adjusting for race and sex in addition to age (Model 2), the effect waned
slightly while remaining significant (β = -46.7 bp, p=0.025). The fully-adjusted model
included the addition of BMI, CRP and homocysteine levels, educational status, smoking
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status, and alcohol intake (Model 3), low B12 status remained significantly associated
with shorter telomere length (β = -55.1 bp, p=0.01).

b. Folate Status and Telomere Length
In the age-adjusted linear regression model (Model 1), suboptimal folate status
was negatively associated with mean telomere length (β = -67.9 bp, p=0.023) (Table
2.3). After adjusting for race and sex (Model 2), the association strengthened slightly, and
suboptimal folate status continued to be associated with a shorter mean telomere length
(β = -76.1 bp, p=0.011) compared to sufficient folate status. In the fully adjusted model
for folate status (Model 3), suboptimal folate status remained significantly associated
with a lower mean telomere length (β = -68.9 bp, p=0.026) compared to sufficient folate
status. No association between elevated folate status and telomere length was found in
any regression model.

c. Interaction of B12 and Folate Status and Telomere Length
The interaction of B12 status and folate status was evaluated in the fully adjusted
model. The F-test yielded borderline significance (p = 0.16). When age was included in
the interaction of B12 and folate, the F-test was nearly significant at p = 0.06.

d. Interaction of B12 and Folate Status and Telomere Length Stratified by Age
Table 2.4 represents data from the interaction of B12 and folate status in the fullyadjusted multiple linear regression model, stratified by age categories of 20 – 39 years, 40
– 59 years, and >60 years. The F-tests testing the interaction between B12 and folate
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status, after stratifying by age, yielded p-values of 0.43, 0.02, and 0.23, respectively.
There was a significant interaction between vitamin B12, folate, and age within those 40 –
59 years, or middle-aged. Specifically, among middle-aged adults, low B12/elevated
folate status was significantly associated with a shorter mean telomere length (β = -382.5
bp, p=0.007) compared to those sufficient in both nutrients of the same age group. A
significantly longer mean telomere length was observed in those with sufficient B12 and
elevated folate in the same age group (β = 111.0 bp, p=0.009). This association was not
present in the other age groups. No interaction associations were found in those over 60
years of age.

D. Discussion
We observed an interaction among B12 status, folate status and age and telomere
length in adult men and women. Specifically, we found that low B12 status in the
presence of elevated folate level was significantly associated with a shorter mean
telomere length in middle-aged adult men and women.
Few studies have investigated the role of one-carbon metabolism factors on
telomere length. Of the studies conducted, none have reported an association with
vitamin B12 status and telomere length, while the relationship with folate status and
telomere length has demonstrated varied results (Liu et al., 2013; Paul et al., 2009, 2014).
To our knowledge, no studies have defined B12 status utilizing serum vitamin B12 along
with MMA levels as we have, with the aim of investigating its association with telomere
length in the presence of elevated folate.
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Several studies have demonstrated negative health outcomes associated with
elevated folate levels in the presence of low B12 status (Brito et al., 2016; Deng, Wang,
Wang, & Kwok, 2017; Morris et al., 2005; Morris et al., 2007, 2012; Selhub, Morris, &
Jacques, 2007). We found that in middle-aged participants with low B12 status, the
presence of elevated folate levels may be detrimental to telomere length. Given the β
coefficient for age in our simple linear regression model yielded an estimate of 14.1 bp
telomeric attrition per each one-year increase in participant age, we used this coefficient
to predict the amount of biological aging in those with low vitamin B12 and elevated
folate levels. The advanced telomeric attrition of 382 bp in this group can be interpreted
as an additional 27 years of biological aging. In other words, among middle-aged adults,
those with low vitamin B12 status in the presence of elevated folate levels had
biologically aged 27 years beyond their nutrient-sufficient, age-equivalent counterparts.
While the mean age of the low B12/elevated folate group is slightly higher than the total
sample population mean age (54.0 years and 50.1 years, respectively), these middle-aged
adults are biologically-aged closer to the oldest age category (mean age 72.0 years) with
respect to telomere length.
Aging is the most influential, non-modifiable factor for telomere length. Youth is
strongly associated with longer telomeres, and a linear decline occurs with age, regardless
of intervening factors (Blackburn et al., 2015; Rode et al., 2015). Our data yielded less
variation in telomere length among the younger (20–39 years) and older (>60 years)
groups compared to those of middle age (40–59 years). The difference in mean telomere
length (longest to shortest) within each of the three age categories (youngest to oldest)
were 144.5 bp, 420.5 bp, and 143.3 bp, respectively. Thus, difference in mean telomere
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length from the shortest to the longest, for those 40–59 years old is nearly three-fold that
of the other two age groups, indicating greater telomeric variability within the middleaged.
In contrast, when vitamin B12 status was sufficient, elevated folate did not have a
negative effect on telomere length in this same group of middle-aged adults and could be
viewed as protective. Our findings were in line with those reported by Morris et al.
(2007) who reported finding a protective effect of higher folate concentrations when
vitamin B12 levels were sufficient versus low. Morris et al. reported poorer cognitive
functioning in older adults with low B12 levels in the presence of elevated folate
compared to normal folate levels. However, when B12 was sufficient, less cognitive
impairment was observed when folate levels were elevated compared to when they were
normal (Morris et al., 2007).
The findings from our study are of public health importance, in that the
consequences of low vitamin B12 status may be more detrimental than previously
thought. Historically, vitamin B12 deficiency has often been masked by low folate
concentrations; whereas, repleting serum folate levels corrects the overt symptomatology.
However, left untreated, chronic vitamin B12 deficiency will result in permanent
neurological damage.
Our study’s importance is two-fold. Foremost, to our knowledge, it is the first
study to demonstrate that low vitamin B12 status is associated with a significantly shorter
mean telomere length in adult men and women. Previous studies neglected to use
additional biomarkers, such as methylmalonic acid (MMA), as indicators of vitamin B12
status, potentially misclassifying individuals with low B12 as sufficient and biasing the
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study toward the null (Liu et al., 2013; Paul et al., 2014). Telomeric shortening is a
known response to oxidative stress, and shorter telomeres are associated with numerous
chronic health conditions. If telomere length is used as an indicator of overall health
status, individuals with low B12 status are at greater risk than those sufficient in the
nutrient.
Secondly, had our study solely used the current diagnostic cutoff for vitamin B12
deficiency of <148 pmol/L to categorize status, we would have failed to identify 13.3%
of the population who had low vitamin B12 status. This would be equivalent to 43.2
million people in the United States, for whom low vitamin B12 status could go
undiagnosed. Low vitamin B12 status could pose a significant medical and financial
burden on our already strained healthcare system.
Our finding of a nearly significant interaction between B12 and folate status, age
and telomere length is of public health importance. We did find a significant association
between low B12 and elevated folate status and telomere length among middle-aged
adults. The molecular mechanism behind the negative effects of elevated folate on
telomere attrition in middle-aged adults with low B12 status remains elusive. While our
data indicate a possible protective effect provided by elevated folate when B12 status is
sufficient, elevated folate levels should be considered potentially harmful when vitamin
B12 status is low. Folic acid fortification programs may need to consider the possible
population benefits of concomitant fortification with vitamin B12. The potential negative
impact of elevated folate status in the presence of low vitamin B12 warrants further
investigation.
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E. Strengths and Limitations
This study provides a novel finding concerning vitamin B12 status and telomere
length. We utilized an additional measure of vitamin B12 (MMA) to more accurately
capture the B12 status of our population. To our knowledge, this has not previously been
done with the aim of investigating vitamin B12 status and telomere length.
In addition, we investigated the joint classification of vitamin B12 and folate status
on telomere length, which we believe to be an innovative concept. Additionally, our data
were taken from the NHANES (1999-2002), a nationally representative database, which
provided a large and diverse sample population.
Limitations of this study include the cross-sectional study design structure, which
does not allow for determinations of causality. Telomere length was measured using realtime PCR, which may not be as accurate at measuring absolute telomere length as the
Southern Blot method. We also did not use weighted data; thus, we are unable to
extrapolate percentage findings to the general U.S. population.
F. Areas of Further Study
While we did not investigate dietary or supplemental vitamin B12 or folate/folic
acid data in this study, we believe it is an area with future research potential for those
studying food patterns, given the metabolic complexity and dichotomy of dietary sources
for nutrients involved in one-carbon metabolism. Nonetheless, serum and plasma
biomarkers are viewed as superior indicators of overall nutrient status to dietary intake
data. In addition, we feel it would be of great interest to examine the association of
vitamin B6 (pyridoxal 5’ phosphate, PLP) and telomere length given its role in onecarbon metabolism, as well as its role in neurotransmitter synthesis. To date, only one

75

study examined PLP in relation to telomere length and no association was found.
However, the authors found a significant relationship between high plasma cysteine
levels and shorter telomere length (Liu et al., 2013). Cysteine is produced from
homocysteine in a double vitamin B6-dependent enzymatic process with serine. The
authors encourage caution in interpreting the results due to the lack of a significant linear
trend.
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CHAPTER 3
IRON STATUS AND TELOMERE LENGTH IN ADULT MEN AND WOMEN
A. Introduction
Telomeres are repetitive, non-coding nucleotide sequences at the end of
chromosomes (5’- TTAGGG – 3’) which protect them against damage during replication.
Telomeric shortening occurs during cellular division, and cells undergo apoptosis when
telomeres reach critical length, as part of the normal aging process. However, shorter
telomeres have been associated with several chronic conditions such as cardiovascular
disease, hypertension, type 2 diabetes, Alzheimer’s disease, and certain cancers,
independent of chronological age. Thus, suggesting its role as biomarker for aging in
eukaryotic cells.
Oxidative stress has also been linked to several of the aforementioned chronic
conditions, as well as the process of aging including shortened telomere length
(Tomiyama et al., 2012; Von Zglinicki & Martin-Ruiz, 2005). Iron, an essential
micronutrient, has been investigated for its role in oxidative damage. Nearly 65% of iron
in the body is associated with hemoglobin; however, the importance of iron extends well
beyond its oxygen carrying ability. The remaining iron is stored in hepatocytes as ferritin
and hemosiderin (as Fe+3), or in the spleen, bone marrow, and/or muscle tissue. Iron is
involved in numerous metabolic processes as a part of heme in a cluster with sulfur, or by
itself. It functions as a component of proteins involved in DNA synthesis, such as
ribonucleotide reductase, and part of the catalytic site of cytochromes and peroxidases.
Iron also acts as a cofactor for dozens of enzymes, including the reactive oxygen species
(ROS) quenching enzymes catalase and myeloperoxidase (Gropper et al., 2009a).
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Reactive oxygen species such as the superoxide radical (O2●), hydroxyl radical
(●OH), and hydrogen peroxide (H2O2) are generated in the body and are typically
quenched by antioxidants and/or enzymes. However, a disruption in the equilibrium and
subsequent ROS overload, can result in oxidative damage. Ferric iron (Fe+2) is released in
high concentrations from lysosomal apoptosis resulting from the cell damage. This
excessive free iron can be a catalyst for further reactions (i.e. Fenton reaction) from
which ROS are formed; thus perpetuating the cycle and leading to oxidative stress
(Kepinska et al., 2015).
Research on elevated iron status and telomere length has demonstrated
dichotomous results (Mainous III et al., 2014; Mainous III et al., 2013; Shin & Baik,
2017). Mainous III et al. found that high transferrin saturation percentage (TS%) was
associated with shorter telomere length in their 2013 study of 1,009 predominantly NonHispanic white participants. However, in a subsequent study by Mainous III et al. (2014),
the researchers found no significant association between elevated TS% and telomere
length after adjusting for confounders in a sample of 669 participants of mixed
race/ethnicity.
To our knowledge, no study has investigated the association of iron deficiency or
iron deficiency anemia (IDA) on telomere length. Iron deficiency is a leading risk factor
for death worldwide, and common among women and children (Zimmermann & Hurrell,
2007). In the United States, 9–11% of nonpregnant women between the ages of 16 and 49
years are iron deficient, with 2–5% having IDA (World Health Organization, 2017).
Among older adults, IDA is associated with a higher risk of falls, increased
hospitalization, impaired mental function, and an increased risk of death (World Health
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Organization, 2017). Oxidative stress and lower antioxidant levels have been reported in
iron deficient subjects (Pra et al., 2012). Iron restriction has been shown to decrease DNA
synthesis and cell proliferation, and reduce ribonucleotide reductase activity, all leading
to genomic instability (Pra et al., 2012). Thus, providing more reason to explore the
association of ID/IDA on telomere length.
Our aim was to investigate the association of iron status on telomere length in
adult men and women from a nationally representative sample. We hypothesized that
men and women with either suboptimal or elevated iron status would have a shorter mean
telomere length compared to those with normal iron status.
B. Material and Methods
1. Study Population
Data from NHANES (National Health and Nutrition Examination Survey) cycles
1999-2000 and 2001-2002 were used in the analyses. The NHANES is conducted by the
National Center for Health Statistics (NCHS), which is part of the Centers for Disease
Control and Prevention (CDC) and is responsible for publishing health statistics on a
nationally representative sample of the US population. The NHANES survey data include
information on demographic, socioeconomic, dietary, and health-related questions, as
well as a laboratory and physical examination component. Participants are selected using
a multistage cluster sampling design with oversampling of persons aged 60 and older,
African Americans, and Hispanics.
Eligible participants included men and women aged 20 years and older who had
blood stored for DNA analysis and subsequent mean T/S ratio data available (n = 7827).
All eligible participants had complete data on sex, C-reactive protein (CRP) levels, and at
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least two of the following variables used to categorize iron status: serum iron, serum
ferritin, erythrocyte protoporphyrin concentration, transferrin saturation percentage,
and/or hemoglobin levels.
Exclusion criteria included men and women with an elevated serum creatinine
(1.7 mg/dL (n = 85) or 1.5 mg/dl (n = 45), respectively), and those with liver and kidney
disease. The kidneys are responsible for producing erythropoietin, a hormone that
prompts bone marrow to synthesize red blood cells (RBC). Thus, kidney disease often
results in fewer RBCs and anemia; while chronic liver disease is frequently associated
with hematological abnormalities including iron deficiency anemia and iron overload.
Liver disease was defined as those who answered yes MCQ170L (do you still
have a liver condition) (n = 155), as well as those with elevated liver enzymes (ALT
≥125 U/L, AST ≥80 U/L, and Alkaline Phosphatase ≥169 U/L; three standard deviations
above the mean) (n = 2). Kidney disease was defined as those who answered yes to
questions KIQ020 (ever told you had weak/failing kidneys) (n = 211). Women with a
positive pregnancy test (code URXPREG) were also excluded (n = 445), bringing the
loss of participants to 943. After reviewing for outliers and/or possible erroneous values
via scatterplot data, participants with serum ferritin levels >500 ng/mL (n=172), mean
telomere length greater than 10,000 bp (n=3), and those with a serum iron level greater
than three standard deviations above the mean were excluded from the study (n=10). The
inclusion of covariates (described below) brought the total number of participants with
complete data available for the multiple linear regression analyses to 5,908.
2. Variables
a. Telomere Length
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Telomere length was our primary outcome. With each NHANES data collection
cycle, blood samples are obtained and analyzed immediately. A small portion of the
blood was reserved for future analysis of DNA, including telomere length. The telomere
length assay was performed by Dr. Elizabeth Blackburn at the University of California,
San Francisco (Cawthon, 2002). Polymerase chain reaction (PCR) methodology was used
to measure the telomere length (T) relative to a standard reference DNA (S) producing a
T/S ratio. Samples had been assayed in duplicate, three times on three different days,
resulting in 6 data points that were then averaged. The final interassay coefficient of
variation was 6.5%. The formula reported in the NHANES database for converting T/S
ratio to a more intuitive base pair variable is (3,274 + 2,413 * (T/S)). This formula is
calculated based on the comparison of telomeric restriction fragment (TRF) length from
Southern Blot analysis and T/S ratios using DNA samples from the human diploid
fibroblast cell line IMR90 (Cawthon, 2002; Needham et al., 2013).
b. Iron Status
The main exposure was iron status, which was determined using an algorithm of
serum iron (Fe), serum ferritin, erythrocyte protoporphyrin level (EPP), transferrin
saturation percentage (TS%), C-reactive protein level (CRP), hemoglobin level (hb) and
sex. Cutoff levels for determining iron status were taken from the World Health
Organization (WHO) (World Health Organization, 2001) and Iron Status Indicators
(Cusick, Looker, Cogswell, Pfeiffer, & Grummer-Strawn, 2008).
Serum iron measures the amount of ferric (Fe3+) iron in the body mainly bound to
transferrin (a primary iron transport protein). This measurement does not capture the
divalent iron bound to hemoglobin. Serum iron level alone is not a good indicator of
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overall iron stores, nor is it a sensitive measure for iron deficiency (Cusick et al., 2008).
Therefore, it was used in conjunction with other measures of iron in defining iron status.
Ferritin, the primary storage protein for iron, is widely used to indicate available
iron in the body. Low ferritin levels (<15 ug/L) are highly associated with iron deficiency
(ID) and iron deficiency anemia (IDA) (Cusick et al., 2008; World Health Organization,
2001). However, ferritin is an acute phase respondent and levels will rise in response to
inflammation. In participants with elevated ferritin levels (>200 ng/mL and >300 ng/mL
for women and men, respectively), we used a CRP cutoff value of >10 mg/L to indicate a
possible acute-phase response of ferritin to inflammation. These participants were
classified with sufficient iron status if they did not have at least one additional biomarker
of abnormal iron status.
Hemoglobin (Hb) is also widely used in diagnosing anemia, specifically IDA,
since it binds approximately 70% of the body’s total iron. We used the WHO cutoff for
IDA of <12 g/dL Hb for women, and <13 g/dL Hb for men as an acceptable cobiomarker for suboptimal iron status (World Health Organization, 2001).
Erythrocyte protoporphyrin (EPP) is a precursor of heme and levels rise when
iron stores are inadequate for hemoglobin production. In addition to ID, infection,
inflammation, and lead-poisoning will also result in an elevated EPP level. In the absence
of infection, measurement of EPP is the preferred method for detecting ID once ferritin
levels drop below normal (World Health Organization, 2001).
Transferrin saturation percentage (TS%) is the measure of total iron bound to
transferrin, an iron transport protein, and is the ratio of serum iron to the total iron
binding capacity of transferrin (TIBC). A TS% <16 is indicative of IDA (Zimmermann &
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Hurrell, 2007), while excess of ≥55% indicates iron overload, or hemochromatosis
(Mainous III, Gill, & Carek, 2004). A TS% of <20 is considered indicative of suboptimal
iron status.
3. Iron Status Categorization
We used the above-mentioned biomarkers of iron status to categorize participants
as having suboptimal, sufficient, or elevated iron status. Participants were considered to
have suboptimal iron status if they had two or more of the following criteria: a serum
ferritin level ≤15 µg/L, EPP level >80 µg/dL, TS% <20, or Hb <12 for women and <13
for men.
To define elevated iron status, we used one or more of the following criteria: TS%
≥50, serum iron level of ≥155 µg/dL for women or ≥160 µg/dL for men, serum ferritin
level of ≥150 µg/L for women or ≥200 µg/L for men along with a CRP <10 mg/L.
Participants with elevated ferritin and elevated CRP levels, but no other abnormal
markers for iron status were classified as sufficient. Participants were classified with
sufficient iron status if they did not meet the set criteria for suboptimal or elevated iron
status. Thus, participants sufficient in iron had serum ferritin levels ≥15 µg/L and <150
µg/L for women and <200 µg/L for men, EPP levels <80 µg/dL, Hb ≥12 g/dL for women
and ≥13 g/dL for men, TS% ≥20 and <50, and serum iron levels <155 µg/dL for women
and < 160 µg/dL for men.

4. Demographic Data
The demographic covariates for this study included age, sex and race/ethnicity.
Age was a continuous variable in years, sex was coded “male” or “female,” and
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race/ethnicity was coded “White/non-Hispanic,” “Mexican/Hispanic,” “Black/nonHispanic,” and “Other/Multi-Racial.”
Markers of socioeconomic status included educational status and annual
household income. Educational status consisted of “≤11th grade,” “high school graduate
or GED equivalent,” and “some college or beyond.” Annual household income was
determined to be non-significant in the model and was later dropped from further
analyses.
Smoking status was categorized as “never,” “former,” and “current” smokers.
Current smokers were further categorized by average number of cigarettes smoked per
day. The “never” group consisted of those participants who answered no to question
SMQ020 (smoked at least 100 cigarettes in life?). Former smokers were those who
answered yes to SMQ020, but no to SMQ040 (do you now smoke cigarettes?). Current
smokers were those who answered 1 or 2 (every day or some days, respectively) to
question SMQ040 (do you now smoke cigarettes?). This group was further categorized
using the answer to question SMD070 (# cigarettes smoked/day now?), into <10
cigarettes/day, 10 to 19 cigarettes/day, and ≥20 cigarettes/day. The smoking variable was
based on cigarette smoking only. Other methods of smoking or use of chewing tobacco
were not assessed.
Alcohol intake was categorized as “never,” “former moderate,” “former heavy,”
“current moderate,” and “current heavy.” Never drinkers were those answering no to
having had at least 12 alcoholic drinks over the past 12 months and no to having had at
least 12 alcoholic drinks in a lifetime. Former drinkers were those who answered yes to at
least 12 drinks in a lifetime, but no to having consumed alcohol over the past 12 months.
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Former drinkers were divided into moderate and heavy intakes. Heavy drinkers answered
yes to ever having ≥ five drinks every day. Current drinkers were also divided into
moderate and heavy alcohol intake. Current moderate drinkers consumed an average of ≤
two drinks/day, while current heavy drinkers consumed ≥ three drinks/day. Blood
glucose status was defined as normal, borderline, and diabetes using an algorithm of
biochemical markers including percent hemoglobin A1c (%A1c), fasting and non-fasting
plasma glucose levels, as well as medical history questionnaire data. Participants were
categorized as having diabetes if they answered yes to taking insulin, to having been told
they have diabetes by a doctor, and/or to taking oral glucose agents. Biochemical data for
diabetes included a %A1c of ≥6.5, a fasting plasma glucose of ≥126 mg/dL, a plasma
glucose of ≥ 200 mg/dL, and/or a fasting glucose of ≥126 mg/dL with an %A1c ≥5.7, but
<6.5. Participants were categorized as borderline blood glucose status if they answered
yes to having been told they have pre-diabetes. Biochemical data for borderline diabetes
included a %A1c ≥5.7 but <6.5% with a fasting plasma glucose ≥100 mg/dL, but <126
mg/dL. The remaining participants were categorized as having normal blood glucose
status if they did not meet the above criteria for impaired glucose. Those lacking data on
two or more of these markers were categorized as missing.

C. Statistical Analysis
Data analyses were performed using STATA/IC version 13.1 to test our
hypothesis that low, as well as elevated iron status is associated with shorter telomere
length in adult men and women. The continuous variables included age, body mass index
(BMI), serum iron concentration, serum ferritin level, transferrin saturation percentage
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(TS%), erythrocyte protoporphyrin (EPP) concentration, and hemoglobin (Hb) level were
reported as the adjusted mean (SE) by sex and iron status (suboptimal, sufficient,
elevated). Categorical variables included race, educational status, annual household
income, smoking status, alcohol intake status, and blood glucose status, and were
reported as counts (%) by sex and iron status. The age-adjusted mean telomere length
was calculated for the categorical variables by sex and exposure status. Two-sample Ttest, Analysis of variance (ANOVA) and Chi-Squared test were used to examine whether
covariate distributions differed across sex and iron status subgroups (suboptimal,
sufficient, elevated). A p-value of < 0.05 was considered statistically significant for all
tests. The main outcome and exposures had equal variances based on results of Levenes’s
test for homoscedasticity.
We tested our main hypotheses by iron status and telomere length in a multiple
linear regression model adjusting for potential cofounding variables. The abovementioned covariates were assessed for their effect on telomere length or confounding
with iron status. A multiple F-test was used to test the significance of the parameters in
the model. If a variable demonstrated no effect on the relationship between telomere
length and our exposure variables (p>0.05) the parameter was eliminated from the model.
The normality of the continuous variables was assessed via graphical methodology, T/S
ratio and BMI were subsequently log-transformed to achieve greater homoscedasticity.
We presented the telomere data as base pair units.
We conducted a linear regression model of iron status and telomere length
adjusting for age alone, reported in model 1. Data are presented as the change in mean
telomere length base pair (bp). We used the log-transformed mean telomere (T/S) ratio in
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the linear regression analysis, prior to the calculation of bp, to determine the β coefficient
for age. We later used this value in determining an estimate of telomeric shortening
associated with biological aging. The regression coefficient for age was -0.0059 (0.6%),
which corresponded to telomere length reduction of 14.3 bp per each one-year increase in
participant age. Model 2 represents the multiple linear regression that included race and
sex, in addition to age. We chose to conduct the analyses in stages due to the particularly
strong correlation of these three variables with telomere length. Model 3 is the fullyadjusted model that builds on model 2 by including BMI, educational status, smoking
status, and alcohol intake status.
To investigate effect modification, we created interaction terms for iron status and
sex, race, and age. We tested the interaction terms for significance in the various models.
If significant, we stratified the linear regression models by the variable and utilized
multiple F-test analysis for significance.

D. Results
1. Descriptive Statistics
Table 3.1 presents descriptive data for the 5,908 participants by sex in our study
population (50.4% female). The mean ages for men and women were 50.0 and 50.4
years, respectively. Non-Hispanic (NH) white participants made up 52.4% of the
population, 16.9% were NH-black, 28.1% were Mexican/Hispanic, and 2.6% were multiracial. Given the small sample size of the multi-racial group, we consider any significant
findings to be only suggestive.

87

The mean age of men with suboptimal iron status was significantly older than the
mean age of women with suboptimal iron status. Whereas the mean age for women with
elevated iron status was significantly higher compared to men (p <0.001). Furthermore,
men and women with suboptimal and elevated iron status, separately, differed
significantly in all iron status parameters except for erythrocyte protoporphyrin levels
among those with suboptimal iron status and serum iron among those with elevated iron
status. C-reactive protein (CRP) was significantly higher among those with suboptimal
iron status compared to those with sufficient iron status, and tended to be higher overall,
in women compared to men. Body mass index (BMI) also tended to be higher in women
compared to men (Table 3.1).
A greater percentage of women (17.3%) had suboptimal iron status compared to
men (4.0%). Whereas men had a higher prevalence of elevated iron status compared to
women (30.5% and 13.3%, respectively). Elevated iron status was similar among all
racial/ethnic groups (Table 3.1). NH-black participants were more likely to have
suboptimal iron status (14.6%) compared to NH-white (8.8%), Mexican/Hispanic
(12.2%), or multi-racial (7.7%) participants. When stratified by sex, a significantly higher
percentage of NH-black and Mexican/Hispanic women had suboptimal iron status
compared to NH-white women.
The distribution of blood glucose status was similar between men and women,
with 11.4% of men and 10.5% of women having diabetes. Among male participants with
diabetes, 39.3% had elevated iron status, while only 29.4% and 28.9% of men with
normal and borderline blood glucose, respectively, had elevated iron status. A similar
pattern was found in women; 18.5% of women with diabetes had elevated iron status,
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whereas 12.2% and 15.7% of those with normal and borderline blood glucose,
respectively, had elevated iron status (Table 3.1).
Women of all ethnic/racial groups had longer mean telomere lengths than men;
furthermore, NH-black women had the longest age-adjusted mean telomere length
(5943.5 bp) of all ethnic/racial groups, followed by NH-black men (5855.5 bp) (Table
3.2).

2. Inferential Statistics
a. Iron Status and Telomere Length
Table 3.3 represents data from multiple linear regression models of iron status
and telomere length. In the age-adjusted model (Model 1), elevated iron status was
significantly associated with shorter telomere length (β = -48.8 bp, p=0.007). After
adjusting for race and sex in addition to age (Model 2), the effect was reduced slightly
while remaining significant (β = -41.1 bp, p=0.025). The fully-adjusted model included
the addition of body mass index (BMI), educational status, smoking status, and alcohol
intake status (Model 3). Annual household income and blood glucose levels were not
significant in the model and were therefore omitted from further investigation. In the
fully adjusted model (Model 3), elevated iron status remained significantly associated
with shorter telomere length (β = -36.7 bp, p=0.045). Suboptimal iron status was not
associated with telomere length in any models analyzed.
The model-based estimate of age-related telomeric attrition in this study was 0.0059 (0.6%), which corresponded to 14.3 bp. Thus, each year of chronological
“normal” aging was associated with a telomeric loss of 14.3 bp. The difference in

89

telomere length in participants with elevated iron status (-36.7 bp) would be equivalent to
2.6 years of additional “biological” aging in this group.

b. Interaction of Iron Status and Sex, Race, or Age
The interaction term of iron status and sex was not significant (p = 0.67), nor were
the interaction terms of iron status and race (p = 0.61) or iron status and age (p = 0.63).
Thus, no further analyses were performed on the interaction terms.

E. Discussion
There is evidence that elevated iron status is associated with shorter telomere
length (Mainous III et al., 2013), but the results have been inconsistent (Mainous III et
al., 2014). We expanded our investigation to include suboptimal iron status, in addition to
elevated iron status, given the high prevalence of iron deficiency (ID) in the United
States, where 10% of Non-Hispanic (NH)-whites, 19% of NH-blacks and 22% of
Mexican/Hispanics aged 20 – 49 years are iron deficient. (US Department of Health and
Human Services. Centers for Disease Control and Prevention., 2002).
We found a small, but statistically significant association between elevated iron
status and shorter mean telomere length among adult men and women from this
nationally representative sample. The model-based estimate for biological aging using the
T/S ratio β-coefficient for age of -0.006% (equivalent to -14.3 base pairs) suggested that
those with elevated iron status are biologically two and one-half years older than their
iron-sufficient counterparts. Although the distribution of iron data was different between
men and women, as well as between the ethnic/racial groups and age, we did not find a
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significant interaction between the tested variables, indicating no effect modification by
sex, race, or age on iron status.
Elevated iron status, primarily as hemochromatosis, has been associated with
detrimental health outcomes including cirrhosis of the liver, pancreatic dysfunction
leading to diabetes, and cardiovascular disease (Richardson, Mcnamee, & Simmonds,
2018). We were not able to assess occurrence of the HFE mutation which leads to
hereditary hemochromatosis in our study population. However, Mainous III and
colleagues (2013) found that elevated iron phenotype, but not hemochromatosis (HFE
genotype) was associated with shorter telomere length, indicating that it may be the
elevated iron status rather than the specific genetic makeup that is associated with
telomeric attrition.
Although we did not find a significant association with impaired blood glucose
levels and telomere length, we did note that a significantly greater percentage of
participants with diabetes had an elevated iron status (39.3%) compared to those with
normal blood glucose levels (29.4%). This finding is in concordance with previous data
supporting an increased risk of diabetes associated with elevated iron status (Montonen et
al., 2012).
Non-Hispanic (NH) black participants were more likely to have suboptimal iron
status, as were women; however, this did not reflect in a shorter mean telomere length for
either group. Overall, we did not find a significant association between suboptimal iron
status and shorter telomere length, although our study had sufficient power to observe a
relationship if one indeed existed. While all participants were categorized with at least
two biomarkers of iron deficiency, we used a transferrin saturation percentage (TS%)
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cutoff of <20%, rather than the 16% indicated by the World Health Organization (WHO)
to define iron deficiency (ID). Nonetheless, the cutoff of <20% had also been suggested
in defining poor iron status (Daniels, 2010). In our study, 195 of the 750 participants with
suboptimal iron status had a TS% ≥16 but <20%. Of these participants, 112 had serum
ferritin levels >15 µg/L but met at least one of the remaining criteria for suboptimal iron
status. No difference was found when suboptimal iron status was classified using TS% of
≤16 compared to <20% in our analyses.
Iron deficiency is the most common nutritional disorder in the world, and is
associated with increased levels of oxidative stress and decreased antioxidant defenses
(Pra et al., 2012). While iron is essential for DNA synthesis via ribonucleotide reductase,
suboptimal iron status does not appear to be associated with telomeric attrition as we
initially hypothesized. To our knowledge, there are no published studies on iron
deficiency and telomere length.

F. Strengths and Limitations
This study filled a knowledge gap on suboptimal iron status and telomere length
in adult men and women. We utilized multiple biomarkers of iron in determining
suboptimal and elevated iron status. By doing so, we strengthened our ability to correctly
identify participants who were truly suboptimal or who had elevated iron status.
Furthermore, our data was taken from the National Health and Nutrition Examination
Survey (NHANES 1999 – 2002) which provided a large, diverse sample population.

1. Limitations
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Micronutrient status can be difficult to study in vivo due to the challenges in
obtaining valid biomarker data. Determinants of iron status are known to fluctuate
depending on certain health parameters. For example, chronic disease and acute
infections may result in abnormal hematology; thus, making an accurate assessment
based on one timepoint come into question. It is possible, despite our best efforts, that we
misclassified participants within the suboptimal and sufficient groups, thus nullifying the
results. Further limitations include the cross-sectional study design structure, which does
not allow for determinations of causality. We also did not use weighted data; thus, we are
unable to extrapolate percentage findings to the general U.S. population.

G. Area of Future Research
Further research on the potential association between suboptimal iron status and
telomere length is warranted. Well-designed prospective studies that include dietary and
biomarker data on micronutrient intake and status would contribute to answering
questions on causality.

H. Summary
A common thread in the progression of aging is the accrual of genetic/DNA
damage. Premature aging diseases, such as Werner and Bloom syndromes, have provided
insight into how DNA instability accelerates the aging process, but do not completely
elucidate the matter. Telomeric attrition is considered to be a primary hallmark of aging
and thus, measurement of telomere length has been proposed to be an indicator of
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biological aging (Aviv, 2002; López-Otín et al., 2013). Nutrient status is a modifiable
factor that has been associated with telomere length.
In our study, less than optimal micronutrient status was significantly associated
with a shorter mean telomere length. Specifically, after stratifying by age, we found a
significant interaction between low vitamin B12 and elevated folate status in middle-aged
adults. The telomeric attrition of 382 base pairs in this group was equivalent to nearly 27
years of additional biological aging using the model-based estimate for aging. This
interaction was not observed in the younger or older age groups; however, middle-age
could be considered the most vulnerable time for telomeres. Telomere length in this age
group was also the most variable in our study, suggesting that telomeres during middleage may be more susceptible to factors influencing attrition, such as poor nutrient status.
Similarly, we found a negative association between elevated iron status and
telomere length. Although we hypothesized a relationship, we did not find an association
between suboptimal iron status and telomere length. Furthermore, we did not find an
interaction between iron and age, and therefore could not support our previous findings in
middle-aged adults. Overall, our study was novel in approach, and successfully
contributed to the current literature on micronutrient status and telomere length.
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Table 1.1:
Age-adjusted characteristics of eligible participants from the National Health and Nutrition Examination Survey (1999-2002)
by vitamin B12 and folate status (N=5,941).
Total
Mean (SE)

Low
B12 status2

Sufficient
B12 Status

p-values 5

Suboptimal
Folate Status3

Sufficient
Folate Status

Elevated
Folate Status4

p-values5

Age (yrs)

50.1 (0.2)

58.0 (0.6)

48.7 (0.3)

< 0.001

43.7 (0.9)

48.5 (0.3)

60.5 (0.6)

< 0.001

Body Mass Index (kg/m2)

28.3 (0.1)

27.9 (0.2)

28.4 (0.1)

<0.001

29.0 (0.3)

28.4 (0.1)

27.3 (0.2)

< 0.001

Serum B12 (pmol/L)

387.3 (3.8)

291.0 (9.7)

405.0 (4.0)

< 0.001

325.8 (14.6)

374.3 (4.2)

473.3 (9.5)

< 0.001

MMA (nmol/L)

151.6 (1.3)

305.2 (2.9)

123.3 (1.2)

< 0.001

167.3 (5.4)

151.6 (1.5)

131.0 (3.5)

NS

Serum Folate (nmol/L)

32.0 (0.2)

28.3 (0.5)

32.7 (0.2)

0.02

11.3 (0.4)

27.9 (0.1)

59.5 (0.3)

< 0.001

CRP (mg/L)

4.5 (0.1)

4.4 (0.3)

4.5 (0.1)

NS

6.2 (0.4)

4.4 (0.1)

4.0 (0.3)

0.005

Homocysteine (umol/L)

8.7 (0.0)

10.5 (0.1)

8.4 (0.0)

< 0.001

12.3 (0.2)

8.7 (0.0)

7.4 (0.1)

< 0.001

Total
N (%)

Low B12
Status2

Sufficient B12
Status

p-values5

Suboptimal
Folate Status3

Sufficient
Folate Status

Elevated
Folate Status4

p-values5

3016 (50.8)
2925 (49.2)

488 (53.0)
433 (47.0)

2528 (50.4)
2492 (49.6)

NS

215 (54.7)
178 (45.3)

2408 (52.7)
2165 (47.3)

393 (40.3)
582 (59.7)

3085 (51.9)
1676 (28.2)
1021 (17.4)
159 (2.7)

589 (64.0)
210 (22.8)
88 (9.6)
34 (3.7)

2496 (49.7)
1466 (29.2)
933 (18.6)
125 (2.5)

< 0.001

164 (41.7)
109 (27.7)
109 (27.7)
11 (2.8)

2212 (48.4)
1396 (30.5)
843 (18.4)
122 (2.7)

709 (72.7)
171 (17.5)
69 (7.1)
26 (2.7)

1931 (32.5)
1410 (23.7)
2600 (43.8)

354 (38.4)
243 (26.4)
324 (35.2)

1577 (31.4)
1167 (23.3)
2276 (45.3)

< 0.001

93 (23.7)
157 (40.0)
143 (36.4)

1519 (33.2)
1106 (24.2)
1948 (42.6)

255 (26.2)
211 (21.6)
509 (52.2)

1222 (23.0)
2298 (43.3)
1789 (33.7)

250 (30.0)
351 (42.1)
233 (27.9)

972 (21.7)
1947 (43.5)
1556 (34.8)

< 0.001

101 (29.3)
152 (44.1)
92 (26.7)

925 (22.6)
1775 (43.4)
1388 (34.0)

196 (22.4)
371 (42.3)
309 (35.3)

3139 (52.8)
1650 (27.8)
274 (4.6)
338 (5.7)
540 (9.0)

461 (50.1)
286 (31.1)
33 (3.6)
46 (5.0)
95 (10.3)

2678 (53.4)
1364 (27.2)
241 (4.8)
292 (5.8)
445 (8.9)

176 (44.8)
63 (16.0)
34 (8.7)
42 (10.7)
78 (19.9)

2403 (52.6)
1269 (27.8)
220 (4.8)
276 (6.0)
405 (8.9)

560 (57.4)
318 (32.6)
20 (2.1)
20 (2.1)
57 (5.9)

888 (15.0)
866 (14.6)
266 (4.5)
2516 (42.4)

181 (19.7)
155 (16.8)
44 (4.8)
359 (39.0)

707 (14.1)
711 (14.2)
222 (4.4)
2157 (43.0)

47 (12.0)
46 (11.7)
20 (5.1)
139 (35.4)

672 (14.7)
644 (14.1)
211 (4.6)
1903 (41.6)

169 (17.3)
176 (18.1)
35 (3.6)
474 (48.6)

Gender
Males
Female
Race
Non-Hispanic White
Mexican/Hispanic
Non-Hispanic Black
Multi-Racial
Education
Less than 11th Grade
High School Graduate
Some College/Beyond
Income
Less than $19K/yr
$20K - $54K/yr
Greater than $55K/yr
Smoking Status
Never Smoker
Former Smoker
<10 cigs/d
10 – 19 cigs/d
>=20 cigs/d
Alcohol Intake
Never
Former Moderate
Former Heavy
Current Moderate

0.026
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< 0.001

< 0.001

< 0.001

< 0.001

0.01

< 0.001

< 0.001

Current Heavy
Blood Glucose Status
Normal
Borderline
Diabetes

1405 (23.7)

182 (19.8)

1223 (24.4)

4452 (75.0)
816 (13.7)
673 (11.3)

634 (68.8)
147 (16.0)
140 (15.2)

3818 (76.1)
669 (13.3)
533 (10.6)

<0.001

Continuous data presented as age-adjusted mean (SE)
Categorical data presented as N (%) by B12 status and folate status
1 Low vitamin B12 status defined as serum B12 <148 pmol/L and/or MMA ≥210 nmol/L
2 Two-sample t-test, significance set at <0.05
3 Suboptimal folate defined as serum folate ≤13.4 nmol/L
4 Elevated folate status defined as serum folate ≥45.3 nmol/L
5 Chi-Squared test, significance set at <0.05
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141 (35.9)

1143 (25.0)

121 (12.4)

309 (78.6)
54 (13.8)
30 (7.6)

3439 (75.2)
612 (13.4)
522 (11.4)

704 (72.2)
150 (15.4)
121 (12.4)

0.043

Table 1.2:
Mean telomere length of eligible participants from the National Health and Nutrition Examination Survey (1999-2002) by joint
classification of vitamin B12 and folate status adjusted for age (N=5,941).1

Total
RTL (base pairs)

5749.2 (7.0)

Sufficient B12
Sufficient Folate
(N = 4,366)
5748.4 (9.3)

Sufficient B12
Suboptimal Folate3
(N = 366)
5661.5 (32.4)

Sufficient B12
Elevated Folate4
(N = 922)
5773.8 (20.0)

1

Adjusted for age, presented as mean (SE)
Low vitamin B12 status defined as serum B12 <148 pmol/L and/or MMA ≥210 nmol/L
3
Suboptimal folate defined as serum folate ≤13.4 nmol/L
4
Elevated folate status defined as serum folate ≥45.3 nmol/L
5
ANOVA, Significance set at <0.05
2
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Low B122
Sufficient Folate
(N = 838)
5681.5 (21.8)

Low B122
Suboptimal Folate3
(N = 96)
5703.0 (64.6)

Low B122
Elevated Folate4
(N = 151)
5674.9 (50.9)

p-values
< 0.001

Table 1.3:
Multiple linear regression models of vitamin B12 status, folate status, and telomere length in participants from the National Health and
Nutrition Examination Survey (1999-2002) N=5,941.
Model 11

Model 22

Model 33

β, (95%CI)

p-value

R2

β, (95%CI)

p-value

R2

β, (95%CI)

p-value

R2

-56.6 (-97.2, -15.9)
Ref

0.006
---

0.169

-46.7 (-87.4, -6.0)
Ref

0.025
---

0.184

-55.1 (-97.1, -13.1)
Ref

0.01
---

0.193

-67.9 (-126.6, -9.2)
Ref
25.6 (-14.9, 66.1)

0.023
--0.216

-76.1 (-134.5, -17.8)
Ref
14.0 (-27.0, 55.0)

0.011
--0.504

-68.9 (-129.4, -8.4)
Ref
7.0 (-34.6, 48.5)

0.026
--0.742

B12 Status4
Low
Sufficient

Folate Status5
Suboptimal
Sufficient
Elevated

0.169

1

0.184

Adjusted for age
Adjusted for age, sex, race, B12 or folate status
3
Adjusted for age, sex, race, B12 or folate status body mass index†, C-reactive protein level†, homocysteine level†, educational status, smoking status,
alcohol intake status
4
Low B12 status defined as serum B12 ≤148 pmol/L and/or MMA ≥210 nmol/L
5
Suboptimal folate status defined as serum folate ≤13.4 nmol/L; elevated folate status defined as serum folate ≥45.3 nmol/L
†
Log-transformed data
2
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0.193

Table 1.4:
Telomere length by joint classification of vitamin B12 and folate status stratified by age in eligible participants
from the National Health and Nutrition Examination Survey (1999-2002) (N=5,941).1
Mean Telomere Length (bp)
20 – 39 years (n = 2068)

p

40 – 59 years (n = 1935)

p

>60 years (n = 1938)

p

Ref

--

Ref

--

Ref

--

Sufficient B12/Suboptimal Folate3

-108.1 (-214.2, -1.9)

0.046

-108.3 (-223.6, 7.0)

0.07

-32.0 (-180.9, 116.9)

0.673

Sufficient B12/Elevated Folate4

-25.6 (-128.8, 77.7)

0.627

111.0 (28.2, 193.9)

0.009

-33.7 (-92.2, 24.8)

0.259

-131.2 (-230.1, -32.4)

0.009

-1.0 (-91.3, 89.4)

0.983

-48.4 (-114.0, 17.1)

0.148

157.9 (-83.8, 399.7)

0.200

11.9 (-285.7, 309.6)

0.937

203.9 (-48.8, 456.7)

0.114

70.2 (-288.4, 428.8)

0.701

-382.5 (-658.2, -106.7)

0.007

50.9 (-73.7, 175.4)

0.423

B12/Folate Status

Sufficient B12/Sufficient Folate

Low B122/Sufficient Folate
Low B122/Suboptimal Folate3
2

4

Low B12 /Elevated Folate

Data presented as mean telomere length (95% CI), significance set at 0.05
Adjusted for age, sex, race, BMI†, C-reactive protein level†, homocysteine level†, educational status, smoking status, alcohol intake
2 Low vitamin B status defined as serum B <148 pmol/L and/or MMA ≥210 nmol/L
12
12
3 Suboptimal folate defined as serum folate ≤13.4 nmol/L
4 Elevated folate status defined as serum folate ≥45.3 nmol/L
1

†

Log-transformed data
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Table 2.1:
Characteristics of eligible participants from the National Health and Nutrition Examination Survey (1999-2002) by sex and
iron status (N=5,908).
Men (N = 2933)

Women (N = 2975)

Continuous Data

Total Men
Mean (SE)

Suboptimal
Iron Status

Sufficient
Iron Status

Elevated
Iron Status

Total Women
Mean (SE)

Suboptimal
Iron Status

Sufficient
Iron Status

Elevated
Iron Status

Age (years)

50.0 (0.3)

63.3 (1.7)*

49.5 (0.4)

49.3 (0.6)**

50.4 (0.3)

46.3 (0.8)*

50.3 (0.4)

56.2 (0.9)**

Body Mass Index (BMI)
(kg/m2)

27.8 (0.1)

29.2 (0.5)

27.6 (0.1)*

28.1 (0.2)

28.7 (0.1)

30.0 (0.3)

28.4 (0.1)*

28.0 (0.3)

Serum Iron (µg/dL)

95.3 (0.7)

53.9 (3.2)*

89.9 (0.8)**

112.5 (1.1)

81.3 (0.7)

47.6 (0.4)*

84.4 (0.7)**

108.8 (1.6)

Serum Ferritin (µg/L)

158.2 (1.7)

81.6 (7.0)*

111.4 (1.7)**

268.2 (2.5)***

77.0 (1.7)

37.6 (2.6)*

66.0 (1.2)**

187.0 (2.9)***

27.4 (0.2)

13.7 (1.0)*

25.7 (0.2)**

33.0 (0.3)***

22.3 (0.2)

11.9 (0.4)*

23.2 (0.2)**

31.4 (0.4)***

47.4 (0.7)

87.1 (1.7)

45.9 (0.4)*

45.0 (0.6)**

61.9 (0.7)

106.0 (2.0)

53.1 (1.0)*

50.9 (2.3)**

Hemoglobin (hb) (g/dL)

15.2 (0.02)

13.6 (0.1)*

15.2 (0.0)**

15.4 (0.0)***

13.5 (0.02)

12.3 (0.0)*

13.7 (0.0)**

13.8 (0.0)***

C-reactive protein (CRP)
(mg/L)

3.6 (0.1)

7.7 (0.6)*

3.9 (0.2)**

2.3 (0.2)***

5.1 (0.1)

6.3 (0.4)*

5.1 (0.2)**

3.4 (0.4)***

MCV (fL)

90.5 (0.1)

85.2 (0.4)*

90.5 (0.1)

91.2 (0.2)

89.6 (0.1)

84.7 (0.2)*

90.5 (0.1)

91.3 (0.3)

Hb A1c %

5.57 (0.0)

5.53 (0.1)

5.54 (0.0)

5.64 (0.0)

5.54 (0.0)

5.62 (0.0)

5.51 (0.0)

5.64 (0.0)

Categorical Data

Total Men
N (%)

Suboptimal
Iron Status

Sufficient
Iron Status

Elevated
Iron Status

Total Women
N (%)

Suboptimal
Iron Status

Sufficient
Iron Status

Elevated
Iron Status

1564 (53.3)
486 (16.6)
813 (27.7)
70 (2.4)

67 (4.3)
24 (4.9)
25 (3.1)
1 (1.4)

1022 (65.4)
307 (63.2)
545 (67.0)
48 (68.6)

475 (30.4)
155 (31.9)
243 (29.9)
21 (30.0)

1530 (51.4)
511 (17.2)
848 (28.5)
86 (2.9)

205 (13.4)
122 (23.9)
178 (21.0)
11 (12.8)

1123 (73.4)
306 (60.0)
576 (67.9)
58 (67.4)

202 (13.2)
83 (16.2)
94 (11.1)
17 (19.8)

974 (33.2)
670 (22.8)
666 (22.7)
623 (21.2)

43 (4.4)
23 (3.4)
27 (4.1)
24 (3.9)

614 (63.0)
432 (64.5)
429 (64.4)
447 (71.8)

317 (32.6)
215 (32.1)
210 (31.5)
152 (24.4)

930 (31.3)
727 (24.4)
806 (27.1)
512 (17.2)

197 (21.2)
109 (15.0)
149 (18.5)
61 (11.9)

599 (64.4)
507 (69.7)
566 (70.2)
391 (76.4)

134 (14.4)
111 (15.3)
91 (11.3)
60 (11.7)

559 (21.2)
1365 (51.7)
719 (27.2)

26 (4.7)
46 (3.4)
30 (4.2)

373 (66.7)
874 (64.0)
486 (67.6)

160 (28.6)
445 (32.6)
203 (28.2)

655 (24.9)
1311 (49.8)
666 (25.3)

131 (20.0)
223 (17.0)
99 (14.9)

445 (67.9)
905 (69.0)
483 (72.5)

79 (12.1)
183 (14.0)
84 (12.6)

1283 (43.7)
1018 (34.7)
145 (4.9)
175 (6.0)

46 (3.6)
57 (5.6)
7 (4.8)
1 (0.6)

848 (66.1)
659 (64.7)
97 (66.9)
122 (69.7)

389 (30.3)
302 (29.7)
41 (28.3)
52 (29.7)

1862 (62.6)
617 (20.7)
123 (4.1)
159 (5.3)

362 (19.4)
89 (14.4)
17 (13.8)
25 (15.7)

1259 (67.6)
441 (71.5)
87 (70.7)
117 (73.6)

241 (12.9)
87 (14.1)
19 (15.5)
17 (10.7)

Transferrin Saturation
Percentage (TS %)
Erythrocyte Protoporphyrin
(EPP) (ug/dL)

Race
Non-Hispanic White
Non-Hispanic Black
Mexican/Hispanic
Multi-Racial
Education
Less than 11th Grade
High School Graduate
Some College
Beyond College
Income
Less than $19K/yr
$20K - $54K/yr
Greater than $55K/yr
Smoking Status
Never Smoker
Former Smoker
<10 cigs/d
10 – 19 cigs/d
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>=20 cigs/d

312 (10.6)

6 (1.9)

196 (62.8)

110 (35.3)

214 (7.2)

23 (10.8)

159 (74.3)

32 (15.0)

Alcohol Intake
Never
Former Moderate
Former Heavy
Current Moderate
Current Heavy

230 (7.8)
365 (12.4)
210 (7.2)
1173 (40.0)
955 (32.6)

14 (6.1)
24 (6.6)
12 (5.7)
44 (3.8)
23 (2.4)

157 (68.3)
241 (66.0)
141 (67.1)
780 (66.5)
603 (63.1)

59 (25.6)
100 (27.4)
57 (27.1)
349 (29.8)
329 (34.4)

668 (22.5)
501 (16.8)
51 (1.7)
1348 (45.3)
407 (13.7)

132 (19.8)
98 (19.6)
12 (23.5)
212 (15.7)
62 (15.2)

445 (66.6)
335 (66.9)
34 (66.7)
962 (71.4)
287 (70.5)

91 (13.6)
68 (13.6)
5 (9.8)
174 (12.9)
58 (14.3)

Blood Glucose Status
Normal
Borderline
Diabetes

2192 (74.7)
408 (13.9)
333 (11.4)

68 (3.1)
30 (7.4)
19 (5.7)

1479 (67.5)
260 (63.7)
183 (55.0)

645 (29.4)
118 (28.9)
131 (39.3)

2253 (75.7)
409 (13.8)
313 (10.5)

375 (16.6)
72 (17.6)
69 (22.0)

1604 (71.2)
273 (66.8)
186 (59.4)

274 (12.2)
64 (15.7)
58 (18.5)

Continuous data presented as unadjusted mean (±SD) by sex and iron status
Two sample T-test (*, **, *** denotes statistically significant differences between men and women by iron status)
Significance set at 0.05
Categorical data presented as N (%) by sex and iron status
Suboptimal iron status defined as ≥2 of the following: ferritin level <15 µg/L, EPP >80 ug/dL, TS% <20, hb <12 for women
and <13 for men.
Elevated iron status defined as the following: TS% ≥50 or ferritin level ≥ 150 µg/L for women and ≥ 200 µg/L for men with
CRP <10 mg/L or serum iron ≥ 155 µg/dL for women and ≥ 160 µg/dL for men.
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Table 2.2:
Age-adjusted mean telomere length by sex, ethnicity/race and iron status in eligible participants from the National Health and
Nutrition Examination Survey (1999-2001).
Telomere Length by Iron Status in Men (N = 2,933)

Race
Non-Hispanic White
Non-Hispanic Black
Mexican/Hispanic
Multi-Racial

Total Men
N (%)

Suboptimal
Iron Status

Sufficient
Iron Status

Elevated
Iron Status

5694.3 (5666.6, 5722.1)
5855.5 (5800.8, 5910.3)
5658.1 (5621.1, 5695.0)
5725.2 (5579.4, 5871.0)

5662.9 (5524.5, 5801.3)
6161.2 (5892.9, 6429.4)
5750.1 (5523.9, 5976.2)
5917.2 (4382.3, 7452.1)

5705.9 (5671.4, 5740.5)
5866.3 (5795.8, 5936.7)
5661.8 (5615.8, 5707.9)
5744.0 (5538.0, 5950.0)

5673.8 (5622.6, 5724.9)
5789.9 (5684.6, 5889.3)
5640.2 (5569.5, 5710.9)
5672.8 (5315.0, 6030.7)

Telomere Length by Iron Status in Women (N = 2,975)

Race
Non-Hispanic White
Non-Hispanic Black
Mexican/Hispanic
Multi-Racial

Total Women
N (%)

Suboptimal
Iron Status

Sufficient
Iron Status

Elevated
Iron Status

5734.5 (5705.6, 5763.3)
5943.5 (5888.9, 5998.2)
5728.5 (5694.7, 5762.2)
5796.7 (5675.5, 5617.9)

5701.1 (5620.6, 5781.5)
5973.0 (5854.2, 6091.8)
5736.4 (5659.1, 5813.7)
5776.5 (5238.0, 6315.0)

5751.4 (5718.1, 5785.7)
5918.7 (5846.1, 5991.3)
5741.6 (5700.1, 5783.2)
5804.0 (5604.4, 6003.5)

5671.6 (5590.5, 5752.7)
5991.7 (5844.8, 6138.6)
5632.7 (5526.2, 5739.3)
5785.1 (5357.6, 6212.7)

Data presented as age-adjusted mean telomere length (95% CI)
Suboptimal iron status defined as ≥2 of the following: ferritin level <15 ng/mL, EPP >80 ug/dL, TS% <20, hb <12 for women and <13 for men.
Elevated iron status defined as the following: TS% ≥50 or ferritin level ≥ 150 ng/mL for women and ≥ 200 ng/mL for men with CRP <10 mg/L or serum iron ≥ 155 ug/dL for women and ≥ 160 ug/dL for men.
†
Log-transformed data
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Table 2.3: Multiple linear regression of iron status and telomere length in participants from the National Health and Nutrition Examination
Survey (1999-2001) (N = 5,908).
Model 11

Iron Status
Sufficient
Suboptimal
Elevated

Model 22

β, (95%CI)4

p-value

-Ref15.7 (-31.9, 63.2)
-48.8 (-84.4, -13.2)

--0.518
0.007

R-sq

0.171

Model 3 3

β, (95%CI)4

p-value

-Ref-5.9 (-54.0, 42.3)
-41.1 (-77.0, -5.2)

--0.812
0.025

1

R-sq

0.185

β, (95%CI)4

p-value

-Ref2.5 (-45.7, 50.6)
-36.7 (-72.6, -0.8)

-0.787
0.045

R-sq

0.193

Adjusted for age
Adjusted for age, gender and race/ethnicity
3 Adjusted for age, gender, race/ethnicity, BMI†, education status, smoking status, and alcohol intake status
4 Represents the change in mean telomere length per year
Suboptimal iron status defined as ≥2 of the following: ferritin level <15 ng/mL, EPP >80 ug/dL, TS% <20, hb <12 for women and <13 for men.
Elevated iron status defined as the following: TS% ≥50 or ferritin level ≥ 150 ng/mL for women and ≥ 200 ng/mL for men with CRP <10 mg/L or serum iron ≥ 155 ug/dL for women and ≥ 160 ug/dL for men.
†
Log-transformed data
2
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